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I. INTRODUCTION 
Distribution of Pyrrolizidine Alkaloids 
Pyrrolizidine alkaloids (PAs) are found in a large number of plant 
species such as Compositae, Leguminosae and Boraginaceae. All climates and 
areas of the world have representatives of these plants (Bull et al., 1968). Of 
special interest in Oregon are Senecio jacobaea (tansy ragwort) and Senecio 
vulgaris (common groundsel) because of their prevalence in animal grazing 
areas. Senecio jacobaea is a biennial plant with a green leafy stem and yellow 
clustered flower head (Kingsbury, 1964). Senecio vulgaris is a low annual herb 
with a green leafy stem and yellow flowers.  Senecio jacobaea contains six 
major pyrrolizidine alkaloids: jacobine, jacoline, jaconine, jacozine, senecionine 
and seneciphylline (Bull et al., 1968). Many of these alkaloids are cytotoxic 
and are often responsible for poisoning livestock and humans (Mattocks, 1986). 
Many of the toxic PAs are allylic esters of the bases retronecine or its 
stereoisomer heliotrioline with toxicities varying according to the nature of the 
esterified necic acid (Fig. I-1). PAs can be monoesters, open diesters or closed 
diesters, the latter being the most hepatotoxic (Smith and Culvenor, 1981). H 
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The tissue distributions of PAs in animals after the administration of 
radiolabelled PAs has been studied. Eastman and Segall (1982) investigated 
the distribution of ["C]-labelled senecionine and seneciphylline in lactating 
mice. At 16 hr after an i.p. injection of senecionine (82 mg/kg), about 96% of 
the radioactivity had been recovered in the urine (75%), feces (14%), expired 
CO2 (0.21%) and the milk (0.04%). A relatively high level in liver (1.92%) 
reflects the potential for hepatotoxicity by this PA compared to small portion 
in the blood (0.32%), kidney (0.05%) and lung (0.03%).  Some of the 
radioactivity in liver from senecionine or seneciphylline is bound to proteins, 
RNA and DNA. The distribution of [3H]- dehydroretronecine (DHR), a pyrrolic 
degradation product of PAs, has been measured in male rats given an s.c. dose 
of 65 mg/kg (Hsu et al., 1974).  There was a rapid general distribution of 
radioactivity throughout the body tissues.  Unlike PAs, DHR was not 
preferentially bound in liver. However, there was a very large amount in the 
glandular part of the stomach. Excretion of DHR occurred via the urine (25% 
in 24 hr) and the bile. 
Metabolism of PAs 
PAs are rather chemically inert.  It is, therefore, unlikely that they 
would be able to react with cell constituents under physiological  conditions. 
On the other hand, metabolites known to be formed from PAs in the liver are 
highly reactive and considerably more cytotoxic than their parent alkaloids. 4 
Once ingested by an animal, the PA can follow various pathways of 
distribution, metabolism and elimination, and the eventual biological effects 
will depend on the balance of these various processes. In laboratory animals, 
the principal known routes of PA metabolism are 1) ester hydrolysis to form 
the corresponding necine bases (retronecine or heliotrioline); 2) conversion to 
N-oxides; and 3) dehydrogenation to form pyrrolic derivatives (Fig. 1-2). The 
first two types of metabolites appear to be detoxication pathways and only the 
last class of metabolites cause cytotoxicity. 
Esterase hydrolysis of a toxic PA leads to the necine and necic acid 
moieties, neither of which are hepatotoxic. There are three kinds of evidence 
relating to the importance of PA hydrolysis for detoxification by mammalian 
enzymes: (1) metabolic activation of PAs is  enhanced in animals whose 
esterase activity is inhibited; (2) direct in vitro measurements of PA hydrolysis 
by esterase preparations show relatively high activities in some animal species; 
and (3) identification of hydrolysis products formed in vivo have demonstrated 
the formation of relatively nontoxic necine bases such as retronecines (Bull et 
al., 1968).  Steric hindrance around the ester groups is a major factor 
controlling hydrolysis of individual PAs (Mattocks, 1982). 
Two major kinds of metabolites are formed by the enzymatic oxidation 
of PAs in animals: pyrrolic derivatives and N-oxides.  The PAs are 
metabolized, via cytochrome P450s, to PA pyrroles through dehydrogenation 
of the pyrrolizidine ring (Fig. 1-3). These highly reactive pyrrole metabolites  5 
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are unstable and either undergo rapid hydrolysis to yield the more stable 
necine pyrrole  [(±)  6,7-dihydro-7-hydroxy-1-hydroxymethy1-5H-pyrrolizine 
(DHP)] or covalently bind to DNA or other tissue nucleophiles (Mattocks and 
White, 1971). DHP is also a strong electrophile capable of alkylating tissue 
constituents.  The cytochrome P450 system (localized in the endoplasmic 
reticulum) attempts to oxidize the alkaloids to the more water soluble 
derivatives which can be more readily excreted, but the chemical instability of 
these intermediates leads to the formation of a more lipophilic and highly toxic 
metabolite. The pyrroles are readily detectable by the strong magenta color 
with a modified Ehrlich reagent. This color reaction is positive in the urine, 
liver and other tissues of rats shortly after they have been given various PAs 
(Mattocks, 1968). 
A second oxidative pathway results in formation of PA N-oxides. This 
reaction is  catalyzed both by cytochrome P450s and flavin-containing 
monooxygenases (FMOs) that are localized in the endoplasmic reticulum of 
primarily the liver. The N-oxides, once formed, are more hydrophilic than 
their parent alkaloids and readily excreted via the urine. In addition, the N-
oxides of PAs are not converted to pyrrolic metabolites by microsomal enzymes 
after oral administration of N-oxides (Mattocks, 1971). However, substantial 
reduction of PA N-oxides back to the parent PAs can occur in the gut 
(Mattocks, 1971). Evidence suggests that the latter reaction may be brought 
about by enzymes in the intestinal flora, rather than from the gut itself. 8 
Antibiotic treatment, which considerably lowers the bacterial content of the 
gut, causes a large decrease in the amount of N-oxide reduced. 
Rates of metabolism of different PAs by hepatic microsomes in vitro vary 
widely, depending on the structure and physical properties of the alkaloid 
(Mattocks and Bird, 1983a). The most lipophilic PAs are metabolized at the 
fastest rates. There are also considerable differences between the proportions 
of pyrroles and N-oxides formed from PAs with different ester groups, and 
these appear to be due to the different degrees of steric hindrance caused by 
the acid moieties at the sites of these metabolic reactions. PAs which are open 
diesters and able to give the greatest hindrance at the C-8 position yield the 
highest proportion of N-oxide compared with pyrrole, whereas monoesters and 
closed diesters in which movement of the acid moiety is restricted, give 
relatively more pyrrole. 
The actions of other mammalian enzymes on PAs may lead to the 
production of other metabolites besides pyrroles and N-oxides.  Liver 
microsomes from female mice produce 19-hydroxysenecionine (6.8%) from 
senecionine (Eastman and Segall, 1982).  The acid moiety of heliotrine is 
demethylated to heliotridine trachelanthate in sheep (Jago, 1969). In ovine 
rumen fluid, heliotrine is converted to the non-toxic base (Lanigan and Smith, 
1970). The 1-aldehyde and the 7-methyl ether derivative of DHR also are 
detectable after the in vitro metabolism of senecionine by mouse liver 
microsomes (Segall et al., 1984). 9 
Toxicity of PAs 
There are many different PAs and this group of compounds can have a 
variety of toxic actions in various species of laboratory and farm animals. All 
the hepatotoxic alkaloids are esters of unsaturated necines.  Different 
unsaturated PAs can produce similar hepatotoxic effects, but their degree of 
toxicity may vary widely (Table I-1). 
Sufficiently large doses of most PAs can cause rapid death. This type 
of acute toxicity is associated with pharmacological actions of the compounds 
rather than cytotoxic actions. Death may be preceded by convulsions or by 
coma. The more lipophilic PAs are especially liable to cause acute toxicity and 
death. 
While PAs produce a diversity of biological effects, the principal 
pathology is irreversible liver cirrhosis with pronounced fibrosis and biliary 
hyperplasia. The sequence of events in acute pyrrolizidine hepatotoxicity is as 
follows (Barnes et al., 1964). The PA is metabolized to a proximal toxin pyrrole 
in hepatic parenchymal cells and this toxin causes necrosis in those cells. 
Some pyrroles escape to damage the endothelium of hepatic veins leading to 
cell proliferation and venoocclusion. Some of the reactive metabolite may 
proceed further by way of the bloodstream to damage other organs such as 
lung. Most of the other tissue lesions and signs of toxicity, including mortality, 
can be related to impaired liver function.  In chronic hepatotoxic disease 
produced by PAs, the liver becomes small and its surface has a granular, 10 
Table I-1. Acute toxicity data of pyrrolizidine alkaloids*. 
PAs 
Heliosupine 
Heliotrine 
Heliotrine N-oxide 
Jacobine 
Monocrotaline 
Retrorsine 
Senecionine 
Seneciphylline 
Animal 
rat 
rat 
rat 
rat 
guinea pig 
rat 
guinea pig 
rat 
guinea pig 
rat 
mouse 
rat 
guinea pig 
Sex* 
M 
M 
M 
F 
M 
M 
F 
M 
M 
F 
M 
M 
U 
M 
F 
U 
Route* 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.p. 
i.v. 
i.p. 
i.p. 
i.v. 
LDS (mg/kg) 
60  
296  
5000  
138  
100'  
109  
230  
>1000  
34  
153  
>800  
50  
64  
77  
83  
50-80  
*Adapted from Chen et al. (1940), Mattocks (1986) and Swick et al. (1982). 
#M, male; F, Female; U, unspecified. 
Intraperitoneal; i.v., intravenous; tI.0100 value. 11 
mottled and nodular appearance. There may be some post-necrotic fibrosis and 
thus the liver continues to undergo cell division cycle but bypasses mitosis. 
The resulting giant hepatocytes (megalocytosis) often show varying degrees of 
degeneration. Other common chronic features of PA hepatotoxicity include a 
proliferation of the bile ducts (Schoental and Magee, 1959). 
Similar toxic actions of PAs have been demonstrated in many different 
animals, but there may be large quantitative differences between animal 
species. The L1350 of retrorsine varies from 34 mg/kg in male rats to over 800 
mg/kg in guinea pigs (White et al., 1973). This difference is mainly due to the 
ability of the animal to convert the PAs to their pyrrolic and/or N-oxide 
metabolites. 
Some animal species show a distinct sex difference in their susceptibility 
to PA hepatotoxicity. This again is probably related to tissue differences in PA 
metabolism. Male rats are over four times as susceptible as are females to the 
acute toxicity of retrorsine and with monocrotaline a two-fold difference in 
LD,os exists between males and females (Mattocks, 1972).  In contrast, no 
significant sex difference was found for retrorsine in mice (White et al., 1973). 
A higher toxicity of retrorsine in 14-day-old rats compared to adults has 
been attributed to three factors (Mattocks and White, 1973). Young animals 
have a relatively lower liver weight (2.8% of body weight compared with 4.3% 
in older rats), which makes the dose of PAs to the liver higher in younger rats. 12 
Secondly, there is a higher portion of pyrrolic metabolites bound to liver tissue 
in young rats.  Finally, there is a greater susceptibility to PA-induced 
cytotoxicity in tissues where the cells are rapidly dividing. 
The effects of PAs in animals can be influenced by food intake and 
nutritional status.  Rats fed a low protein diet are more susceptible to the 
toxicity of Senecio jacobaea PAs whereas high protein diets afford some 
protection (Cheeke and Garman, 1974). The acute hepatotoxicity of retrorsine 
is decreased more than three-fold in rats fed only sucrose for 4 days prior to 
injection of the PA and then returned to a normal diet (Mattocks, 1972). 
Incorporation of copper+2 (50 ppm) in the diet of rats increases the 
hepatotoxicity of Senecio jacobaea (Miranda et al., 1981). 
Pretreatment of rats with phenobarbital causes an increase in 
susceptibility to PAs under conditions where the rate of metabolism in rats is 
normally low, but phenobarbital is protective where metabolism is normally 
fast,  even though pyrrole  production  is  increased (Mattocks,  1972). 
Pretreatment with SKF 525A, an inhibitor of cytochrome P450, reduces the 
susceptibility of male rats to retrorsine toxicity.  Pretreatment with zinc' 
lowers the ability of rat liver microsomes to convert PAs to pyrrolic metabolites 
and gives some protection against hepatotoxicity (Miranda et al., 1982). 
Pretreatment of animals with tri-orthocresyl phosphate, an inhibitor of 
esterase activity, can result in a large proportion of PAs being converted to 
pyrrolic metabolites in vivo (Mattocks, 1981). Cysteine pretreatment doubles 13 
the liver glutathione (GSH) level and halves the toxicity of retrorsine whereas 
2-chloroethanol reduces the liver GSH concentrations to one-fourth of control 
values and doubles the alkaloid's toxicity (White, 1976). 
The liver, where many PAs are converted to toxic metabolites, is the 
commonest site of injury by these alkaloids.  There is no evidence that 
substantial amounts of toxic metabolites are formed from PAs in other tissues. 
Thus, the extent to which an extrahepatic tissue is damaged will depend not 
only on its intrinsic susceptibility to damage but also on the amounts of 
reactive PA metabolites that are able to reach the tissue in active form from 
liver. The more reactive the metabolite, the smaller the amount that would 
survive the journey from liver to an extrahepatic tissue in order to cause 
damage. The lung is the most common extrahepatic site for toxic actions of 
PAs. Macrocyclic diesters with 11-members such as monocrotaline and fulvine 
are particularly active in causing pneumotoxicity (Barnes et al.,  1964). 
Monocrotaline pyrrole is less reactive than retrorsine pyrrole (Mattocks, 1969). 
Monocrotaline pyrrole also is more stable than other pyrroles. This may be the 
reason why monocrotaline is more effective in damaging the lung. Early lung 
changes caused by PAs include alveolar edema and hemorrhage. The initial 
injury leads to a progressive thickening of medial walls of small pulmonary 
arteries and veins.  This then results in increased pulmonary pressure, 
endothelial damage and the development of right ventricular hypertrophy 
(Ghodsi and Will, 1981). A normal function of pulmonary endothelial cells is 14 
to remove and metabolize circulating vasoactive substances and drugs. This 
activity may be impaired in animals suffering from PA-induced lung injury. 
Chronic heart damage often occurs as a secondary result of PA-induced 
lung damage.  Thus, right ventricular hypertrophy develops in rats fed 
monocrotaline in the diet (Turner and Lalich, 1965). Cor pulmonale has been 
similarly induced with seneciphylline (Ohtsubo et al., 1977). 
There are reports of kidney damage in animals poisoned with PAs. 
Fulvine damages the epithelium of proximal convoluted tubules in rats 
(Persaud et al., 1970).  Retrorsine causes a severe toxic nephritis with 
damaged glomeruli and hemorrhage in the adrenal glands in monkeys (Van 
der Watt and Purchase, 1970). 
Infrequent enlarged islet cells have been seen in pigs fed Crotalaria 
retusa (Hooper and Scanlan, 1977). Islet cell tumors of the pancreas have been 
reported in rats fed monocrotaline (Hayashi et al., 1977). 
Spongy degeneration in brains of calves and sheep fed with PAs was 
observed due to increased blood ammonia, secondary to the severe liver 
damage: a similar lesion was produced in sheep given ammonium acetate 
intravenously (Hooper, 1972). 
The International Agency for Research in Cancer (IARC) concluded that 
some PAs such as lasiocarpine,  monocrotaline, retrorsine,  riddelliine, 
senecionine and seneciphylline are hepatocarcinogens (IARC, 1976 and 1983). 15 
A mixture of intermedine and lycopsamine extracted from seeds of Amsinckia 
intermedia produced tumors of the pancreas in rats (Schoental et al., 1970). 
A number of PAs such as fulvine, heliotrine, jacobine, monocrotaline, 
retrorsine and senecionine have been shown to be mutagens in bacterial test 
systems (Mattocks, 1986).  The N-oxides of heliotrine, lasiocarpine and 
monocrotaline are  also mutagens (Clark,  1960).  Heliotrine induced 
chromosome damage in human lymphocytes (Kraus et al., 1985). Lasiocarpine 
and its pyrrolic metabolites can exert their antimitotic activities resulting in 
megalocytosis (Samuel and Jago, 1975). 
In summary, many of the PAs produce acute and chronic hepatotoxicity 
with cirrhosis and megalocytosis leading to irreversible liver damage. Some 
PAs are pneumotoxic, producing pulmonary arterial hypertension and right 
ventricular  hypertrophy,  or  carcinogenic  (McLean,  1970)  and show 
mutagenicity in various test systems (White et al., 1983). 
Species differences in response to PAs 
There is a marked variation in the sensitivity of animal species to the 
toxic effects of PAs (Table 1-2). There are several factors that may account for 
species differences in susceptibility and resistance of some animals to PA 
toxicity. These include: 1) lack of PA absorption; 2) degradation of PAs in the 
rumen; 3) lack of hepatic formation of pyrroles; and 4) conjugation  and 
excretion of PAs and pyrroles. 16 
Table 1-2.  Susceptibility of animals to PA intoxication in comparison with 
their rates of in vitro hepatic pyrrole production*. 
Animal  Susceptibility  Pyrrole  LD (% of body weight)* 
Chicken  High  Low  39  
Cow  High  High  4  
Guinea pig  Low  Low  119  
Horse  High  High  8  
Japanese Quail  Low  Low  2450  
Rabbit  Low  High  113  
Rat  High  High  21  
Sheep  Low  Low  302  
*Adapted from Cheeke and Shull (1985). 
*Chronic lethal dose of Senecio jacobaea 17 
(1). Mouse 
The mouse is susceptible to PA poisoning. After feeding tansy ragwort 
which contains the six major PAs such as jacobine, jacoline, jaconine, jacozine, 
senecionine and  seneciphylline,  young male mice  developed edema, 
megalocytosis and cytoplasmic invaginations of hepatocytes (Hooper, 1974). 
In addition to the liver lesions, lung and kidney also were affected.  Mice 
injected  i.p.  with the  alkaloid lasiocarpine  exhibited lesions  of the 
gastrointestinal tract (Hooper, 1975). 
(2). Rat 
Rats are susceptible to both injected and ingested PAs. Livers from rats 
fed Senecio jacobaea developed megalocytosis, vascular congestion and 
hemorrhage (Bull et al., 1968). After consuming a diet containing Crotalaria 
spectabilis seed, rats developed lung lesions including hydrothorax and edema 
(Allen and Carstens, 1970). Kidneys and livers were mildly damaged. The 
LD50 in male rats injected i.p. with retrorsine was 34 mg/kg; senecionine 50 
mg/kg; monocrotaline 109 mg/kg (Mattocks, 1972); and seneciphylline 80 mg/kg 
(Anon,  1949).  Tissue damage associated with acute death included 
hemorrhagic necrosis and congestion of the liver, ascites, and pulmonary 
edema. 
(3) Hamsters 
Hamsters were more susceptible to intoxication by injected alkaloids 
than rats and mice (Rose et al., 1959). Pyrrole production rates were several  18 
times greater in male hamsters than in male rats when both monocrotaline 
and tansy ragwort mixed alkaloids were fed (Shull et al., 1976). 
(4) Guinea pig 
Liver tumors due to pyrrolizidine alkaloid poisoning were not induced 
in guinea pigs (Schoental, 1969; McLean, 1970). Guinea pigs, injected with 
four times the monocrotaline LD50 for rats, remained normal for 6 weeks and 
no pathologic changes were seen at necropsy (Chesney and Allen, 1973). A 
dose of 800 mg retrorsine/kg was not sufficient to kill guinea pigs (White et al., 
1973) and guinea pigs were resistant to the acute hepatotoxic effects  of 
senecionine (McLean, 1970). However, Chen et al. (1940) observed that guinea 
pigs injected intravenously with a 2% solution of seneciphylline in doses of 50-
80 mg/kg died after convulsions. Jacobine is also very toxic to the guinea pig 
(Swick et al., 1982) giving an LD50 similar to that seen in the rat (Bull et al., 
1968). Pyrrole forthation in guinea pigs was 30 times slower than in injected 
rats, while N-oxide production was greater. It thus appears that guinea pigs 
are very resistant to certain PAs but are intoxicated by other PAs, notably 
seneciphylline and jacobine. 
(5) Rabbit 
Rabbits are well recognized to be very resistant to PA-induced toxicity. 
However, a rabbit fed Crotalaria crispata which contained monocrotaline, 
fulvine and crispatine, died after 136 days (Bull et al., 1968). The liver showed 
sign of megalocytosis. Kidney was affected with enlarged proximal convoluted 19 
tubule epithelial cells.  Lungs showed patchy emphysema and enlarged 
alveolar cells.  Among the resistant species, rabbits produce the highest 
amounts of pyrroles in in vitro preparations. The resistance is due to the high 
conjugation and excretion of pyrroles produced. 
(6) Avian species 
Turkeys are very susceptible to poisoning by seed from Crotalaria 
spectabilis which contains monocrotaline (Allen, 1963). Typical histological 
changes occur in the liver with necrosis, bile duct proliferation and fibrosis. 
Chickens also are readily intoxicated by Crotalaria seed and tansy ragwort 
(Campbell, 1956). However, quail differ in their susceptibility to PAs toxicity 
(Buckmaster et al., 1977). Japanese quail allowed to eat 10% tansy ragwort 
in a standard layer mash consumed the mixture for 365 days with no ill 
effects. 
(7) Sheep 
Sheep can consume 300% of their body weight of Senecio jacobaea but 
still survive. The specific organism, named Peptococcus heliotrinreducans, 
responsible for reductive breakdown of heliotrine in sheep rumen has been 
isolated (Lanigan, 1976).  The organism is in competition with rumen 
methanogenic bacteria for molecular hydrogen. 
(8) Cattle 
After consumption of alfalfa hay contaminated with Senecio vulgaris, 
twelve dairy heifers suffered ataxia, prolapsed rectum and congested mucus 20 
membranes (Fowler, 1968). The very firm livers showed megalocytosis and 
excess fibrosis. PAs were found in the milk of cows that had consumed 10 g 
of dried tansy ragwort, but the calves were not affected (Dickinson et al., 
1976). 
(9) Horse 
In horses, neurological disturbances are seen, after consuming PAs, 
including head pressing against solid objects and walking in a straight line 
(Van Es et al., 1929). As a result, drowning is common. Neurological signs in 
horses are due to elevated blood ammonia caused by decreased ability of the 
liver to convert ammonia to urea (Rose et al., 1957). 
(10) Human 
Humans are also subject to pyrrolizidine alkaloid poisoning.  Clinical 
reports on Senecio contamination of bread and tea have been issued from 
Africa and India (McLean, 1970).  Symptoms include abdominal pain, 
distended abdomen, ascites and death. Ingestion of herbal teas prepared from 
Senecio longilobus, which contains riddelliine, retrorsine, seneciphylline and 
senecionine, has been fatal to children in the United States (Huxtable et al., 
1977). Successive intake caused ascites and liver enlargement. 21 
Objectives 
Rats are highly susceptible, whereas guinea pigs are very resistant to 
PA intoxication (McLean, 1970). In guinea pigs, where PA pyrrole formation 
is particularly low, a dose of 800 mg/kg retrorsine is insufficient to kill the 
animals. Pretreatment with phenobarbital which induces cytochrome P450s 
increases the hepatic metabolic activity and the LD50 is lowered to 210 mg/kg 
(White et al., 1973).  Guinea pigs are similarly resistant to monocrotaline 
(Chesney and Allen, 1973) and senecionine (McLean, 1970), but not to jacobine 
or to mixed alkaloids from Senecio jacobaea which are highly toxic at 100-150 
mg/kg (Swick et al., 1982). 
In Sprague-Dawley rats (Williams et al., 1989a) and humans (Miranda 
et al., 1991b), liver microsomal conversion of the PA SN to DHP is catalyzed 
primarily by enzymes belonging to the cytochrome P4503A subfamily.  In 
guinea pigs, however, the orthologs of cytochrome P4502B and P4503A both 
participate in DHP formation by hepatic microsomes (Miranda et al., 1992). 
Cytochrome P4502C11 is responsible for SN N-oxidation in Sprague-Dawley 
rats (Williams et al.,  1989a).  Flavin-containing monooxygenase (FMO) 
accounts for no more than 20 % of the PA N-oxidase activity of Sprague-
Dawley rat liver microsomes (Williams et al., 1989b), but the major catalyst for 
the N-oxidation of SN in guinea pigs is the FMO system (Miranda et al., 
1991a). 22 
We chose for further study the rat and guinea pig as animal models for 
susceptible and resistant species, respectively. We have investigated the 
species/strain difference in terms of the role of cytochrome P450s, flavin-
containing monooxygenase and carboxylesterases  in bioactivation and 
detoxication of the pyrrolizidine alkaloids. The PA senecionine was chosen 
because it has high toxicity in rats but low toxicity in guinea pigs and it is a 
good substrate for the enzymes examined. Jacobine also was studied since it 
is unusually toxic to the guinea pig which is a species resistant to other PAs. 
SPECIFIC OBJECTIVES: 
1.	  To investigate the influence of strain on the metabolism of the PA 
senecionine (SN) using Sprague-Dawley and Fischer 344 rats (strain 
differences between rats). 
2.	  To determine the effect of spironolactone (SPL), a known inducer of 
cytochrome P4503A, on the metabolism of the SN in rats and guinea 
pigs (species differences between rats and guinea pigs). 
3.	  To determine which P450 isozyme is responsible for the bioactivation 
and detoxication of SN in guinea pigs (guinea pigs as resistant animals). 
4.	  To determine which factor is responsible for susceptibility of guinea pigs 
to the PA jacobine (guinea pigs as susceptible animals). 23 
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Abstract 
Wide variations of metabolism of the pyrrolizidine alkaloids (PAs), such as 
senecionine (SN), between animal species are known to exist but little work 
has been done to investigate differences in animal strain. The metabolism of 
SN in Fischer 344 (F344) rats has been studied in order to compare to that of 
the previously studied Sprague-Dawley (SD) rats (Drug Metab. Dispos. 17, 387, 
1989).  There was no difference in DHP (activation) formation by hepatic 
microsomes from either sex of between SD and F344 rats. However, hepatic 
microsomes from male and female F344 rats had greater activity in the N-
oxidation (detoxication) of SN by 88% and 180%, respectively, compared to that 
of male and female SD rats. In a test for optimum pH, the maximum for SN 
N-oxidation by hepatic microsomes in females was pH 8.5 whereas in males SN 
N-oxide formation showed a bimodal pattern with peaks at pH 7.6 and 8.5. 
Use of specific inhibitors showed that SN N-oxide was primarily produced by 
flavin-containing monooxygenase (FMO) in both sexes of Fischer 344 rats. In 
contrast, SN N-oxide formation is known to be catalyzed mainly by P450 
rather than FMO in Sprague-Dawley rats. This study, therefore, demonstrates 
that substantial differences in PA metabolism can exist between animal 
strains. 25 
Pyrrolizidine alkaloids (PAs) are constituents of certain plant species 
(Mattocks, 1986).  Human exposures can occur through the ingestion of 
foodstuffs such as herbal teas, milk, honey, etc. Some of these alkaloids are 
toxic to animals and humans. PAs are metabolized by liver monooxygenases 
yielding PA pyrroles and N-oxides (Mattocks and Bird, 1983a). PA pyrroles 
are considered the ultimate toxic metabolites whereas N-oxides are believed to 
be non-toxic. The PA pyrroles either react with cellular macromolecules or are 
hydrolyzed to form a secondary pyrrole known as (±) 6,7-dihydro-7-hydroxy-1-
hydroxymethy1-5H-pyrrolizine (DHP).  DHP also is a strong electrophile 
capable of alkylating cellular nucleophiles including DNA (White and 
Mattocks, 1972). 
A marked variation exists in the sensitivity of animal species to the toxic 
effects of PAs.  In Sprague-Dawley (SD) rats (Williams et al., 1989a) and 
humans (Miranda et al., 1991b), the microsomal formation of DHP and N-oxide 
from the PA, senecionine (SN), is catalyzed primarily by enzymes belonging to 
the cytochrome P4503A subfamily. Flavin-containing monooxygenase (FMO) 
accounts for no more than 20% of the PA N-oxidase activity of SD rat liver 
microsomes (Williams et al., 1989b). However, FMO was the major catalyst 
of the N-oxidation of SN in guinea pig (Miranda et al., 1991a). 
Recently, evidence was presented that rat strains are highly polymorphic 
in electrophoretic recognizable isoforms of cytochrome P450 (Rampersaud and 
Walz, 1987) and esterases (Simon et al., 1985). Microsomal drug metabolism 26 
in a large number of inbred rat strains varied over a 1.3- to 7.3-fold range 
depending on the enzyme activity being measured (Koster et al., 1989). 
Fischer 344 (F344) rats were found to be significantly different from SD rats 
in terms of the effect of cyclosporine on ethylmorphine N-demethylase and 
aniline hydroxylase activities (Augustine and Zemaitis, 1989). F344 rats also 
produced substantial liver damage associated with the oxidative stress of 
diquat while SD rats displayed only minimal liver necrosis (Tsokos-Kuhn, 
1988). 
Differences in terms of species susceptibility are well documented 
relative to PAs poisoning. However, little work has been done investigating 
strain differences in PAs metabolism. We hypothesized that F344 rats would 
have a different metabolism of PAs compared to SD rats. In this study, we 
present evidence that F344 rats in both sexes had the greater in vitro SN N-
oxidation compared to that found with SD rats.  Another hepatic enzyme 
system (FMO but not P450) in F344 strain is also mainly responsible for the 
N-oxidation of the PA SN in contrast to SD rats. 27 
MATERIALS AND METHODS 
Chemicals. SN was purified from extracts of Senecio jacobaea and the 
DHP and N-oxide metabolite standard were prepared as previously described 
(Kedzierski and Buhler, 1986b).  Glucose-6-phosphate, glucose-6-phosphate 
dehydrogenase,  1- benzylimidazole, methimazole, SKF 525A and 
thiobenzamide were obtained from the Sigma Chemical Co. (St Louis, MO). 
Testosterone and its metabolites were purchased from Steroid Reference 
Collection (London, UK). 
Microsome Preparation. F344 and SD rats (male and female, 8 weeks 
old from Simonson Inc. Gilroy, CA) were starved 24 hr prior to killing. Livers 
were homogenized with 0.1 mM potassium  phosphate buffer, pH 7.4, 
containing 0.15 M KC1 and 1 mM EDTA. Microsomes were prepared by 
standard differential centrifugation and stored in 0.1 M potassium phosphate 
buffer, pH 7.4, containing 20 % glycerol and 0.1 mM EDTA at -80°C. 
Enzyme Assays. The in vitro metabolism of SN by microsomes from rat 
liver was carried out using the procedure described by Miranda et al. (1991a). 
A typical incubation consisted of 0.3 mg microsomal protein, 0.1 M potassium 
phosphate buffer, pH 7.6 or 8.6, 0.5 mM SN, 1 mM EDTA and a NADPH-
generating system (10 mM glucose-6-phosphate, 1.0 units/mg glucose -6-
phosphate dehydrogenase and 1 mM NADP+) in a total volume of 0.5 ml. After 
a 1 hr incubation (formation of DHP and N-oxide was linear up to 1 hr under 28 
the assay conditions used) at 37°C, the reaction was terminated by rapid 
cooling on ice. The mixture was centrifuged at 46,000 g for 45 min at 4°C and 
an aliquot of the supernatant was analyzed by HPLC (Kedzierski and Buhler, 
1986a). When inhibitors (1-benzylimidazole, methimazole or SKF 525A) were 
added, the incubation mixture was first preincubated with the inhibitors at 
37°C for 20 min before the addition of SN. Microsomal protein contents were 
determined by the method of Lowry et al. (1951).  Total cytochrome P450 
content was estimated using a spectral method (Omura and Sato, 1964). 
Testosterone hydroxylase assays were carried out by the method of Wood et al 
(1983). Thiobenzamide S-oxide formation was measured at 370 nm by the 
procedure of Cashman and Hanzlik (1981) at 37 °C in Tricine buffer (pH 8.4), 
with 2 mM NADPH, in the absence of n-octylamine. Statistical analysis was 
carried out using student t-test. 29 
RESULTS 
SN metabolism by microsomes 
In both sexes, there was no significant difference in DHP formation from 
the PA SN by hepatic microsomes from SD and F344 rats (Fig. II-1). However, 
hepatic microsomes from male F344 had a greater SN N-oxide formation of 
88% compared to that from male SD rats. Liver microsomes from female F344 
also exhibited a 180% enhancement of female SD levels of SN N-oxide 
formation. These results may imply that different enzyme systems and/or 
specificities between SD and F344 strains are responsible for SN N-oxidation, 
or that more enzymes active in SN N-oxidation exist in F344 rats. 
Inhibition studies 
In order to examine whether different enzyme systems existing in these 
two strains were responsible for SN N-oxide formation, we employed specific 
chemical inhibitors for cytochrome P450s and FMOs in SN metabolism by F344 
hepatic microsomes. SKF 525A and 1-benzylimidazole, specific inhibitors for 
P450s, decreased DHP formation by 70-95% in.both sexes of F344, however, 
inhibited SN N-oxidation by only 0-30% in male and 40-45% in female F344 
(Table II-1). Williams et al. (1989a) reported that SKF 525A and metyrapone, 
another inhibitor of P450s, inhibited DHP formation 95% and SN N-oxidation 
56-87% in SN metabolism by liver microsomes from male SD rats. 
Methimazole, a competitive inhibitor for FMO, had no inhibitory activity 30 
against DHP production by hepatic microsomes from both sexes of F344. 
However, methimazole decreased SN N-oxidation by 85-96% in both sexes of 
F344. We conclude that DHP formation is catalyzed by the P450 system while 
SN N-oxide is primarily produced by FMO in both sexes of F344 rats. In SD 
rats, however, both DHP and SN N-oxide formations are catalyzed by P450 
systems (Williams et al., 1989a). 
Optimum pH for DHP and SN N-oxide formation 
We tried optimum pH tests since P450 and FMO were known to have 
different optimum pH for maximum activities.  The optimum pH for P450 
appears to be between 7.2 and 7.6 (Sato and Omura, 1978). This contrasts 
with FMO which possesses a pH optimum usually around 8.4-9.2 depending 
on the species and tissue (Ziegler, 1988). DHP was metabolized maximally at 
pH 7.6-7.8 in both sexes of F344 rats (Fig. 11-2 and 11-3).  However, the 
maximum for SN N-oxide production in female F344 was pH 8.5 whereas SN 
N-oxide showed a bimodal pattern with peaks at pH 7.6 and 8.5 in male F344. 
These results also supported that DHP was catalyzed by P450 while SN N-
oxide was primarily produced by FMO in both sexes of F344. 
Thiobenzamide S-oxidation 
We assayed thiobenzamide S-oxidation for further evaluation of FMO 
activities in SD and F344 rats. Thiobenzamide is a specific substrate used to 31 
assay for FMO activity (Cashman and Hanzlik, 1981). The specific activities 
of hepatic microsomes from male F344 thiobenzamide S-oxide was 56% higher 
than male SD rats while there was no difference between female rats of the 
two strains (Fig. 11-4). 
Testosterone hydroxylase activity 
We measured testosterone hydroxylase as an indicator substrate for 
estimation of the relative contributions of different cytochrome P450s. 
Testosterone 6P-hydroxylase activity, which is mostly catalyzed by cytochrome 
P4503A2 (Guengerich et al., 1982), is 50% higher in male SD than in male 
F344 rats (Fig.  11-5).  On the other hand, testosterone 16a- and 16P-
hydroxylase activities, in which P4502C11 and P4502B1 participate (Nebert et 
al., 1987), are 120% and 84% higher in male F344 than that in male SD rats, 
respectively. These results indicate that the activity of P4503A2, which is an 
important enzyme for DHP formation in the SD rats (Williams et al., 1989a), 
is higher in male SD rats than in male F344 rats. Furthermore, the activity 
of P4502C11, which is responsible for SN N-oxidation in SD rats, is higher in 
F344 strain than in SD strain. 
In female rats, testosterone 7a- and 6P-hydroxylase activities were 80% 
and 1500% higher in F344 than those in SD, respectively, whereas 16P-
hydroxylase was 75% higher in SD than that in F344.  Testosterone 16a-
hydroxylase activity was not observed in female SD whereas some activities 32 
were present in female F344. These results denote that the male dominant 
monooxygenase activities, such as P4503A2 and P4502C11, is much higher in 
female F344 while the female dominant monooxygenase activity like P4502A1 
is higher in female SD than in female F344. 33 
DISCUSSION  
There are several possibilities to account for species differences in 
susceptibility and resistance of some animals to PA toxicity. These include 
differences in absorption, degradation, hepatic formation of pyrroles or PA N-
oxides, or conjugation and excretion of PAs and pyrroles (Mattocks, 1986). 
Strain differences may be explained in a similar fashion. 
We have assayed microsomal activities toward SN in order to verify the 
hypothesis that there are strain differences in PAs metabolism between F344 
and SD rats. While there were no differences in DHP formation by hepatic 
microsomes in both sexes of SD and F344 rats, both sexes of F344 rats showed 
the greater N-oxidation of the PA SN compared to that of SD rats. Recently, 
Pan et al.  (1993) demonstrated that F344 rats were resistant to the 
cardiovascular toxicity of monocrotaline pyrrole at doses that cause severe 
damage in SD rats, perhaps due to the presence of more refractory pulmonary 
endothelial cells in F344 rats. It is, therefore, possible that F344 rats may be 
unusually resistant to the toxicities of PAs, both because of the faster 
detoxication that we have observed, but also due to having more refractory 
tissues. 
Evidence based on enzyme inhibition data and optimal pH suggests that 
hepatic microsomal DHP formation was catalyzed primarily by P450 systems 
in both sexes of F344 rats as previously demonstrated in SD rats (Williams et 34 
al., 1989a) and in guinea pigs (Miranda et al., 1991a).  However, SN N-
oxidation was primarily catalyzed by FMO in both sexes of F344 rats. This 
contrasts with SD rats where SN N-oxidation is carried out primarily by 
P4502C11 (Williams et al., 1989a).  This is very similar to the situation in 
guinea pigs which are well known to be very resistant to PA intoxication 
(Chesney and Allen, 1973; McLean, 1970; White et al., 1973). 
Lawton and Philpot (1993a) suggest that all five FMO genes (FMO1, 2, 
3, 4 and 5) present in the rabbit are also present in humans, guinea pig, 
hamsters, rats and mice based on blot analysis of genomic DNA.  With 
respective to substrate specificities of FMOs, the overall size of the nucleophile 
appears to be a major factor limiting access to the 4a-hydroperoxyflavin in 
different FMO isoforms (Nagata et al, 1992; Ziegler, 1993). From the study of 
the substrate specificities of four FMO isoforms in the SN metabolism using 
FMO expressed microsomes (FMO1, 2, 3 and 4), which showed distinct 
substrate specificities against methimazole and n-octylamine (Lawton and 
Philpot, 1993b), only FMO1 expressed microsome exhibited a minimal activity 
of SN N-oxidation (Chung et al., 1993d). 
Thiobenzamide S-oxidation assays showed that male F344 rats had 
greater FMO activity compared to that of male SD rats.  However, the 
interpretation of thiobenzamide S-oxidase activity is rather equivocal since 
there was no difference in FMO activity between females of these two strains, 
even though FMO appeared to be responsible for SN N-oxidation in female 35 
F344 rats. Therefore, we suggest that F344 rats, at least the females, may 
have distinct FMO isoforms from SD rats. 
The results of the testosterone hydroxylase assays were relatively 
ambiguous and difficult to interpret. According to the observed testosterone 
hydroxylase activities, more DHP formation should be occurring with 
microsomes from male SD rats than with microsomes from male F344 rats. 
However, SN conversion to DHP was higher in male F344 rats. If P4503A2 and 
P4502C11 are as important to PA metabolism in F344 rats as they are in SD 
rats, differences in the levels of these P450s in F344 rats may explain better 
than FMO the differences in PA metabolism between these rat strains. This 
equivocal phenomenon may reinforce the need for purification of FMOs and 
confirmation of substrate specificity toward PAs in both strains. 
In conclusion, FMO was the major catalyst for SN N-oxidation whereas 
P450 systems catalyzed formation of pyrrolic metabolites in Fischer 344 rats. 
Unlike Sprague-Dawley rats, Fischer 344 rats exhibit SN oxidation that is 
similar to that of guinea pigs, a species that is resistant to PA toxicity. This 
study, therefore, demonstrates that substantial differences in PA metabolism 
can exist between animal strains. 36 
Table II-1.  Effect of inhibitors on the senecionine metabolism by hepatic 
microsomes from Fischer 344 rats. 
% of Control activity* 
Male  Female 
Inhibitor  DHP  SN NO  DHP  SN NO 
SKF 525A  19  124  31  60 
1-Benzylimidazole  5  71  18  55 
Methimazole  117  15  100  4 
*Control activities for DHP are 2.13 and 0.50 nmole/min/mg protein in male 
and female, respectively. Control activities for SN N-oxide are 5.91 and 0.64 
nmole/min/mg protein in male and female, respectively. Reactions carried out 
at pH 7.6 with SKF 525A (0.5 mM), 1-benzylimidazole (0.1 mM) or 
methimazole (0.25 mM). 37 
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Fig. II-1. Comparison of senecionine metabolism by hepatic microsomes from 
Sprague-Dawley and Fischer 344 rats (SD, Sprague- Dawley; F344, Fischer 344; 
M, Male; F, Female; R, DHP;  ,SN N-oxide).  *Significantly different from 
the corresponding sex of SD rats (p<0.05). 38 
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Fig. 11-2. Effect of pH on the DHP (0) and senecionine N-oxide (I) formation 
by liver microsomes from male Fischer 344 rats upon incubation with SN. 
Reactions were carried out in potassium phosphate (pH 6.8 to 8.2), tricine (pH 
8.4 to 8.8) or glycine (pH 0.0 to 9.8) buffer. 39 
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Fig. 11-3. Effect of pH on the DHP (0) and senecionine N-oxide (IN) formation 
by liver microsomes from female Fischer 344 rats upon incubation with SN. 
Reactions were carried out in potassium phosphate (pH 6.8 to 8.2), tricine (pH 
8.4 to 8.8) or glycine (pH 0.0 to 9.8) buffer. 40 
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Fig. 11-4.  Comparison of thiobenzamide S-oxidation by hepatic microsomes 
from Sprague-Dawley and Fischer 344 rats (SD, Sprague- Dawley; F344, 
Fischer 344; M, Male; F, Female).  *Significantly different from the 
corresponding sex of SD rats (p<0.05). 41 
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Fig. 11-5. Comparison of testosterone metabolism by hepatic microsomes from 
Sprague-Dawley and Fischer 344 rats [SD;Sprague-Dawley, F344;Fischer 344, 
M;Male, F;Female, 7a- (s), 613- (W, 16a- (a) and 1613-hydroxytestosterone 
(M)]. *Significantly different from the corresponding sex of SD rats (p<0.05). 42 
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Abstract 
Spironolactone (SPL), a known inducer of cytochrome P4503A1, was 
injected into rats and guinea pigs in order to investigate species differences in 
pyrrolizidine alkaloid (PA) metabolism. Liver microsomes from treated male 
rats showed an increased (±)-6,7-dihydro-7-hydroxy-1-hydroxymethy1-5H-
pyrrolizine (DHP) formation of 47 % from the PA senecionine (SN) coincident 
with the induction of P4503A1, whereas SN N-oxidation was decreased by 49 
%, probably due to a reduction in hepatic P4502C11 concentrations.  By 
contrast, liver microsomes from SPL-treated female rats exhibited almost a 500 
% increase in both DHP and SN N-oxide production coincident with the 
marked induction of P4503A1. In guinea pigs of both sexes, oral treatment 
with SPL caused an approximately 50 % increased formation of both DHP and 
SN N-oxide by liver microsomes.  Only a slight increase in hepatic 
concentrations of P4503A1 occurred in the treated guinea pigs. Use of the 
P450A1 specific inhibitor, triacetyloleandomycin, showed that P4503A1 played 
the important role in PA metabolism in untreated or SPL treated rats but not 
in both untreated and SPL treated guinea pigs. SPL treatment increased 
testosterone 1613-hydroxylase activity by 100% in both sexes of guinea pigs. 
This study demonstrated that P4503A was not the major enzyme for PA 
metabolism in guinea pigs. 44 
Pyrrolizidine alkaloids (PAs) occur in plants from the families: 
Boraginaceae, Compositae and Leguminosae and some of these alkaloids are 
toxic to animals and humans (Mattocks, 1986). While PAs produce a diversity 
of biological effects, the principal pathology is irreversible liver cirrhosis with 
pronounced fibrosis and biliary hyperplasia. Most of the other tissue lesions 
and signs of toxicity, including mortality, can be related to impaired liver 
function. 
There is, however, a marked variation in the sensitivity of animal 
species to the toxic effects of PAs. Rats are highly susceptible, whereas guinea 
pigs are very resistant to PA intoxication (McLean, 1970; Chesney and Allen, 
1973; White et al., 1973). PAs are metabolized by hepatic monooxygenases, 
located in the endoplasmic reticulum, yielding PA pyrroles and N-oxides 
(Mattocks and White, 1971). PA pyrroles are considered the ultimate toxic 
metabolites, whereas PA N-oxides are more water soluble and relatively non-
toxic  (Mattocks,  1971).  The PA pyrroles  either  react with  cellular 
macromolecules or are hydrolyzed to form a secondary pyrrole such as (±) 6,7-
dihydro-7-hydroxy-1-hydroxymethy1-5H-pyrrolizine (dehydroretronecine; DHP). 
In rats (Williams et al, 1989a) and humans (Miranda et al., 1991a), the 
liver microsomal formation of the PA senecionine (SN) to DHP and SN N-oxide 
is catalyzed primarily by enzymes belonging to the cytochromes P4503A and 
P4502C11, respectively. In guinea pigs, however, the orthologues of P4502B1 
and P4503A participate in DHP formation by hepatic microsomes (Miranda et 45 
al., 1992). Flavin-containing monooxygenase (FMO) accounts for no more than 
20 % of the PA N-oxidase activity of Sprague-Dawley rat liver microsomes 
(Williams et al., 1989b), but this enzyme is the major catalyst for N-oxidation 
of SN in guinea pigs (Miranda et al., 1991b). 
Liver microsomes from dexamethasone (an inducer of cytochrome 
P4503A) treated guinea pigs increased the conversion of SN to DHP only by 
37% (Miranda et al., 1992). We have studied the effect of spironolactone (SPL), 
another P4503A inducer (Heuman et al., 1982), on the metabolism of SN in 
guinea pigs and rats in order to evaluate the role of P4503A and investigate 
further species differences. 46 
Materials and Methods 
Chemicals. 
SN was purified from extracts of Senecio jacobaea and dehydroretronecine 
(DHR) and SN N-oxide metabolite standards were prepared as described 
previously (Kedzierski and Buhler, 1986).  Spironolactone (SPL) and 
triacetyloleandomycin (TAO) were obtained from Sigma Chemical Co. (St. 
Louis, MO). The chemicals and materials used in Western blotting and sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) were purchased 
from Bio-Rad Laboratories (Richmond, CA) and [125IJ-Protein A was obtained 
from ICN Radiochemicals (Irvine, CA). 
Treatments of animals. 
SPL was injected i.p. into male and female Sprague-Dawley rats (200-
220 g, Simonson Inc., Gilroy, CA) and administered i.p. or orally to Hartley 
guinea pigs (400-450 g, Simonson Inc.) at 100 mg/kg body weight in propylene 
glycol (50 mg/ml) for i.p. or in saline (10 mg/ml) for oral administration, twice 
daily, for 3 days. Control animals received only vehicle. Animals were starved 
24 hr prior to killing. 47 
Microsome preparation. 
Animals were anesthetized with carbon dioxide and killed by cervical 
dislocation. The livers were immediately removed and homogenized in ice-cold 
0.1 M potassium phosphate buffer, pH 7.4, containing 0.15 M KC1 and 1 mM 
EDTA. Microsomes were prepared by an initial centrifugation at 9,000 g for 
30 min at 4 °C, with subsequent centrifugation of the supernatant at 105,000 
g for 60 min at 4 °C.  The microsomal pellet was recentrifuged in the 
homogenization buffer, resuspended in 0.1 M potassium phosphate buffer, pH 
7.4, containing 20 % glycerol (v/v) and 0.1 mM EDTA and then stored at 80°C 
until used. 
Metabolism of SN by microsomes. 
The typical incubation with microsomes consisted of 0.3  0.5 mg 
microsomal protein, 0.1 M potassium phosphate buffer, pH 7.6, 0.5 mM SN, 1 
mM EDTA, and a NADPH-generating system (10 mM glucose-6-phosphate, 1.0 
unit/ml glucose-6-phosphate dehydrogenase and 1 mM NADP+) in a total 
volume of 0.5 ml. After 1 hr incubation at 37°C with shaking (100 cycle/min), 
the reaction was terminated by rapid cooling on ice.  The mixture was 
centrifuged at 46,000 g for 45 min at 4°C and an aliquot of the supernatant 
was analyzed by HPLC (Kedzierski and Buhler,  1986a).  When 48 
triacetyloleandomycin (TAO, 0.02 mM) was used to inhibit the reaction, the 
mixture was first preincubated with the inhibitor at 37°C for 20 min before the 
addition of SN. 
Other assays. 
Testosterone metabolism by microsomes was carried out by modification 
of the procedure described by Wood et al. (1983). Protein was determined as 
described by Lowry et al. (1951) with bovine serum albumin as standard. The 
method of Omura and Sato (1964) was used for the determination of total P450 
content. Immunoblotting of microsomal proteins was performed using anti-rat 
P4503A IgG (Oxygen, Dallas, TX), anti-rat P4502B1 IgG, anti-rat P4502C11 
IgG and anti-pig FMO IgG with detection of immunoreactive proteins by [125u_ 
protein A as previoUsly described (Miranda et al., 1991b). Statistical analysis 
was carried out using student's t-test. 49 
Results 
Effect of SPL on cytochrome P450 isozymes. 
We observed no significant SPL-induced changes in the P450 content of 
liver microsomes in rats or guinea pigs of either sex (Fig. III-1). However, SPL 
treatment of male rats caused a 274% increase of 7a-testosterone hydroxylase 
activity [for which P4502A1 is presumed responsible (Waxman, 1988)] (Fig. III-
2). 613-Testosterone hydroxylase activity (in which P4503A1 participates) was 
not significantly increased by SPL treatment in male rats. SPL dosing of male 
rats also decreased 16a- and 16P-hydroxylation of testosterone (for which 
P4502C11 and P4502B1 are responsible, respectively) by 88% and 50%, 
respectively.  In contrast, SPL treatment of female rats resulted in a 89%, 
9900% and 247% increase of 7a-, 6/3- and 16/3-hydroxylation of testosterone, 
respectively, whereas 16a-testosterone hydroxylase was not detectable in either 
untreated or SPL treated animals (Fig. 111-2). 
In  contrast,  i.p.  injection  of SPL increased  1613-testosterone 
hydroxylation by 108% while 7a-, 613- and 16a-hydroxylase activities were 
unchanged in male guinea pigs (Fig. 111-3). SPL treatment (i.p.) did not affect 
testosterone metabolism we detected in female guinea pigs. Oral treatment of 
SPL increased 1613-testosterone hydroxylase activity by 121% and 103% in 50 
male and female guinea pigs, respectively, whereas 7oc-,  6r3- and 16a-
hydroxylase activities were unchanged (Fig. 111-4). 
Immunochemical detection of cytochrome P450s using anti-rat P4503A 
IgG showed that SPL treatment caused a large increase in the levels of 
P4503A in both sexes of rats and a relatively small induction of P4503A in 
both sexes of guinea pigs, dosed either orally or i.p. (Fig. 111-5).  Anti-rat 
P4503A IgG cross-reacted with two bands while the upper band increased due 
to SPL treatment in guinea pigs. The concentration of P4502B decreased by 
about 12% in SPL-treated (i.p.) male rats and i.p. injected female guinea pigs, 
while it increased in female rats (99%), i.p. injected male guinea pigs (24%), 
oral dosed male guinea pigs (23%) and oral dosed female guinea pigs (17%) as 
estimated by densitometric analysis of western blots using anti-rat P4502B1 
IgG (Fig. 111-5). A 26% reduction of cytochrome P4502C11 concentrations, a 
male dominant isoform in rats, was seen in SPL treated male rats as estimated 
by densitometric analysis of western blots using anti-rat P4502C11 IgG (Fig. 
111-5).  Western blot using anti-pig FMO IgG showed that SPL treatment 
would not affect the level of FMO in both sexes of guinea pigs (data not 
shown). 
Effect of SPL on DHP formation. 
DHP formation from SN by SPL treated liver microsomes from male rats 
increased by 47% (Fig. 111-6). By contrast, SPL treatment resulted in a 475% 51 
increase (p < 0.01) in DHP formation by hepatic microsomes from female rats, 
effectively eliminating the sex differences in conversion of SN to DHP seen in 
untreated animals. Inhibition studies with TAO, which is an specific inhibitor 
of P4503A1 (Wrighton et al., 1985; Delaforge et al., 1983), also showed that the 
induced P4503A1 contributed to enhanced DHP production in SPL treated rats 
of both sexes (Table III-1). 
In guinea pigs, i.p. injection of SPL increased DHP formation by 66% in 
males but not significantly in female animals (Fig. 111-6). No differences in 
DHP formation by male and female guinea pig liver microsomes were observed 
upon oral administration of SPL. Inhibition of DHP formation with TAO was 
only 11% to 28% in untreated male and female guinea pigs (Table 111-2). 
Inhibition with TAO also showed that P4503A contributed to only 20% to 27% 
of the DHP production by microsomes from SPL treated guinea pigs, by either 
oral or i.p. 
Effect of SPL on SN N-oxidation. 
SN N-oxide formation was decreased by 49 % after SPL treatment of 
male Sprague-Dawley rats (Fig. 111-7), probably due to a reduction of P4502C11 
(Fig. 111-5).  Inhibition studies with TAO showed that absolute SN N-oxide 
production (the difference in N-oxide formation in the presence and absence of 
TAO) by P4503A1 in treated male rats was almost the same as that observed 52 
in untreated male rats (Table III-1). This was quite interesting since it imply 
that the increased levels of P4503A1 induced by SPL did not contribute to SN 
N-oxidation in treated male rats. Unlike in males, SPL treatment of female 
Sprague-Dawley rats increased SN N-oxidation by 525 % with hepatic 
microsomes (Fig. 111-7), probably as a result of an apparent induction of 
P4503A1 (Table III-1 and Fig. 111-5). Inhibition studies also showed that the 
relative importance of P4503A1 in SN N-oxidation increased after SPL 
treatment in both sexes of rat, whereas the relative role of P4503A1 in DHP 
formation remained unchanged after SPL treatment (Table III-1). 
In guinea pigs, oral administration of SPL resulted in 85 % and 55 % 
increases in hepatic microsomal SN N-oxidation, respectively, whereas i.p. 
injection caused no significant increase in male and female animals, 
respectively (Fig. 111-7). Inhibition studies with TAO showed that P4503A did 
not contribute significantly to SN N-oxidation in untreated and SPL treated 
guinea pigs of either sex (Table 111-2). 53 
Discussion  
There are some conflicting reports in the literature on the effects of SPL 
on the P450 content in rat liver microsomes. Oral administration of SPL at 
100 mg/kg, twice daily for 4 days, decreased the hepatic P450 content of female 
rats but not of male rats (Fujita et al., 1982). Another study showed oral 
dosing with SPL at 100 mg/kg daily for 4 days to female rats produced no 
significant increases in total hepatic P450 (Heuman et al., 1982). A single i.p. 
administration of SPL at 150 mg/kg to male rats led to a 21 % loss of hepatic 
microsomal P450 after 3 hr (Decker et al., 1986). SPL has been shown to act 
initially as a suicide substrate and subsequently as an inducer of the P4503A 
subfamily being more potent in adrenal and testicular tissue than liver (Sherry 
et al., 1986). In this study, however, we observed no significant changes in 
liver microsomal P450 content in either sex of rats or guinea pigs (Fig. III-1). 
Therefore, we agree with the conclusion of the Sherry et al. (1986) study. 
In Sprague-Dawley rats, the conversion of SN to DHP is catalyzed 
primarily by the male dominant P4503A subfamily (Williams et al., 1989a). 
DHP formation in untreated female rats is quite low due to the limited 
presence of this isozyme. However, pretreatment with SPL eliminated the sex 
difference in DHP formation causing a 10-fold greater increase in female rats 
than in males. Inhibition studies showed that P4503A in treated females was 54 
responsible for 82 % of the DHP production. The induced level of P4503A 
paralleled the increased DHP production in female rats. 
The orthologues of cytochromes P4502B1 and P4503A have been shown 
to participate in DHP formation in guinea pig liver microsomes (Miranda et al., 
1992). In guinea pigs, only male liver microsomes from i.p. injection of SPL 
increased DHP formation significantly. Inhibition studies with TAO showed 
that P4503A played a minimal role in DHP formation in both untreated and 
SPL treated guinea pigs. Phenobarbital treatment increased DHP formation 
by 220% in male guinea pigs (Chung and Buhler, 1993c). These results may 
imply the possibility that in the guinea pig P4502B1 is more important than 
P4503A in the bioactivation of SN. 
SN N-oxide formation was decreased following SPL treatment of male 
rats.  This phenomenon is  quite interesting because treatment with 
dexamethasone, another P4503A inducer, increased both DHP and SN N-oxide 
formation (Williams et al., 1989a). The N-oxidation of SN in male Sprague-
Dawley rats is catalyzed primarily by P4502C11 and P4503A2. Cytochrome 
P4503A1 induced by SPL apparently did not 'contribute to SN N-oxidation. 
Instead, the decrease of SN N-oxidation may have been primarily due to the 
loss (69 %) of P4502C11 activity in male rats. A decrease in rat P4502C11 
concentrations following dosing with 3,4,5,3',4',5'-hexachlorobiphenyl or 3-
methylcholanthrene was reported to be due to decreased hepatic P4502C11 
mRNA concentrations (Yeowell et al., 1987). Thus, there is a possibility that 55 
SPL may repress the transcription of P4502C11 although SPL produces less 
striking effects than the compounds that interact with the Ah receptor. 
Unlike the situation in male rats, induced P4503A in female rats played 
an equally important role in both the activation and detoxication of SN, as 
reflected by the 5-fold increase of both DHP and SN N-oxide production. SPL 
treatment also eliminated the sex difference of rats in SN N-oxidation, 
however, in this case, female rats increased but male rats decreased. 
Unlike DHP formation, only oral administration of SPL resulted in 
significant increase of SN N-oxidation in guinea pigs. However, inhibition 
studies with TAO showed that P4503A did not contribute to SN N-oxidation 
in guinea pigs. FMO, a major enzyme for SN N-oxidation in the guinea pig, 
was not induced by SPL treatment. SPL treatment increased P4502B activity 
by over 100% upon oral administration with SPL in both sexes of guinea pigs. 
P4502B may be responsible for the increased SN N-oxidation. However, why 
the increased testosterone 16f3-hydroxylase activity in male guinea pigs with 
i.p. injection of SPL is not reflected by enhanced SN N-oxidation still remains 
to be answered. 
These results showed that the metabolism of SN in guinea pigs could be 
affected by inducing P450 isoforms even though FMO, which is generally not 
inducible by xenobiotics, is a major enzyme for N-oxide formation in this 
species (Miranda et al., 1991b). 56 
In conclusion, our studies showed that SPL caused a marked induction 
of P4503A in rats but only a slight effect in guinea pigs. Furthermore, the 
induced P4503A played an important role in bioactivation and detoxification 
of the PA SN in rats but not in guinea pigs. In addition, SPL treatment also 
reduced the level of P4502C11, another important enzyme in the detoxification 
of SN by male Sprague-Dawley rats. SPL treatment was shown to eliminate 
the sex differences in SN metabolism found in rats. Oral treatment with SPL 
increased testosterone 1613-hydroxylase activity in guinea pigs.  This study 
demonstrated that the cytochrome P4503A subfamily, an important enzyme for 
bioactivation of the PA SN in Sprague-Dawley rats, was not the major enzyme 
responsible for PA metabolism in guinea pigs. 57 
Table III-1. Effect of triacetyloleandomycin, an inhibitor of cytochrome 
P4503A1, on senecionine metabolism by rat liver microsomes. 
Male  Female 
-TAO +TAO %Inhibition  -TAO  +TAO %Inhibition 
DHP 
-SPL  1.55  0.36  77%  0.44  0.15  66% 
+SPL  2.28  0.68  70%  2.51  0.45  82% 
SN N-oxide 
-SPL  3.15  2.08  34%  0.23  0.21  9% 
+SPL  1.62  0.65  60%  1.47  0.28  81% 
Activities are expressed as nmole/min/mg protein. The values represent the 
means of duplicate determinations [-TAO, without triacetyloleandomycin; 
+TAO, with triacetyloleandomycin (0.02 mM); -SPL, untreated; +SPL, SPL 
pretreated]. 58 
Table 111-2. Effect of triacetyloleandomycin, an inhibitor of cytochrome 
P4503A1, on senecionine metabolism by guinea pig liver microsomes. 
Male  Female 
-TAO +TAO %Inhibition  -TAO +TAO %Inhibition 
DHP 
I.P.  
-SPL  0.70  0.61  13%  0.74  0.65  12%  
+SPL  1.15  0.86  23%  0.93  0.74  20%  
Oral  
-SPL  0.43  0.38  11%  0.70  0.50  28%  
+SPL  0.65  0.47  27%  1.10  0.80  27% 
SN N-oxide 
I.P.  
-SPL  2.39  2.51  -5%  2.52  2.39  5%  
+SPL  2.86  2.95  -3%  2.80  2.99  -7%  
Oral  
-SPL  2.02  1.80  11%  2.23  2.43  -9%  
+SPL  3.73  3.51  6%  3.44  3.47  -1%  
Activities are expressed as runole/min/mg protein. The values represent the 
means of duplicate determinations [-TAO, without triacetyloleandomycin; 
+TAO, with triacetyloleandomycin (0.02 mM); -SPL, untreated; +SPL, SPL 
pretreated]. 59 
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Fig. 111-2. Testosterone metabolism by rat liver microsomes. Values represent 
means of four animals ± SE (CM, control male; SM, SPL treated male; CF, 
control female; SF, SPL treated female; 7a, 6(3, 16a and 16P represent the 
position  of hydroxylation  of testosterone,  i.e.  7a OH-T means 7a-
hydroxytestosterone). Asterisk indicates significant difference from controls 
(*p < 0.05; **p < 0.01, Student's t-test). 61 
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Fig. 111-3. Testosterone metabolism by liver microsomes from SPL treated, 
i.p., guinea pigs. Values represent means of four animals ± SE (CM, control 
male; SM, SPL treated male; CF, control female; SF, SPL treated female; 7a, 
613, 16a and 1613 represent the position of hydroxylation of testosterone). 
Asterisk indicates significant difference from controls (*p < 0.05, Student's t-
test). 62 
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Fig. 111-4. Testosterone metabolism by liver microsomes from SPL treated, 
oral dosing, guinea pigs. Values represent means of four animals ± SE (CM, 
control male; SM, SPL treated male; CF, control female; SF, SPL treated 
female;  7a, 6P, 16a and 16(3 represent the position of hydroxylation of 
testosterone). Asterisk indicates significant difference from controls (*p < 0.05, 
Student's t-test). 63 
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Fig. 111-5. Immunochemical detection of cytochrome P4503A1, P4502B1 and 
P4502C11 in liver microsomes from rats and guinea pigs. Each lane contains 
20 jig of pooled microsomes from each treated group (CM, control male; SM. 
SPL treated male; CF, control female; SF, SPL treated female). 64 
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Fig. 111-6. DHP formation from senecionine by liver microsomes from rats and 
guinea pigs. Values represent means of four animals ± SE (C, control; S, SPL 
treated; M, male; F, female). Asterisk indicates significant difference from 
controls (*p < 0.05; **p < 0.01, Student's t-test). 65 
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Abstract  
1.  Guinea pigs are well documented to be resistant to the toxicity of 
pyrrolizidine alkaloids (PAs). We have purified three cytochrome P450s from 
the liver of phenobarbital (PB) treated guinea pig in order to evaluate the role 
of these enzymes in PAs metabolism. 
2.  Reconstituted guinea pig  cytochrome P4502B (Mr=57,512 by mass 
spectrometry; PB inducible) catalyzed the conversion of the PA senecionine 
(SN) to the pyrrolic metabolite (±)6,7-dihydro-7-hydroxy-1-hydroxymethy1-5H-
pyrrolizine (DHP, activation) and SN N-oxide (detoxication) at a minimal rate 
even though hepatic microsomes from PB treated guinea pigs increased DHP 
formation by 224% and SN N-oxidation by 70%. 
3.  A cytochrome P4503A form (Mr=54-56,000 by SDS-PAGE) had lost its 
activity during the final purification processes. However, examination of the 
catalytic activity of semipurified guinea pig P4503A showed substantial 
conversion of SN to DHP. A purified cytochrome P4502C type (Mr=56,496 by 
mass spectrometry) isoform produced SN N-oxide from SN at the rate of 13.3 
nmole /min/mg protein but little DHP formation was detectable. 
4.  Immunoinhibition of SN metabolism by rabbit anti-guinea pig 
cytochrome P4502B, P4502C and P4503A IgG indicated that P4502B played 68 
the most important role (over 70%) in bioactivation of SN in both untreated or 
PB-treated guinea pig while the P4502C and P4503A isoforms seem to have 
little influence (around 13%).  P4502B also contributed along with flavin-
containing monooxygenase to detoxification of SN in both untreated (34%) and 
PB treated (40%) guinea pig. 
5.  This study suggests that cytochrome P4502B plays the most important 
role in SN bioactivation in the guinea pig. 69 
Pyrrolizidine alkaloids (PAs) are found in a large number of plant 
species occurring throughout the world (McLean, 1970).  Many of these 
alkaloids are cytotoxic and carcinogenic and these are often responsible for 
poisoning livestock and people (Mattocks, 1986). PAs are metabolized by liver 
monooxygenases yielding PA pyrroles and N-oxides (Mattocks and Bird, 
1983a). PA pyrroles are considered the ultimate toxic metabolites whereas PA 
N-oxides are believed to be non-toxic.  The PA pyrroles either react with 
cellular macromolecules or are hydrolyzed to form a secondary pyrrole known 
as ( ±) 6,7-dihydro-7-hydroxy-1-hydroxymethy1-5H-pyn-olizine (DHP). DHP also 
is a strong electrophile capable of alkylating cellular nucleophiles including 
DNA (White and Mattocks, 1972). 
Similar toxic actions of PAs have been demonstrated in mary animal 
species, but there may be large quantitative differences (White et al., 1973). 
Guinea pigs are very resistant to the toxicity of PAs (Chesney and Allen, 1973; 
White et at, 1973), but curiously not to that of jacobine (Swick et al., 1982). 
Miranda et al. (1991a) reported that the rate of N-oxidation from the PA 
senecionine (SN) by hepatic flavin-containing monooxygenase (FMO) was much 
higher in the guinea pig than in the rat. Dueker et al. (1992a) demonstrated 
that the guinea pig hepatic microsomal carboxylesterases had the capability 
of hydrolysis of PAs while the rat exhibited no such hydrolytic capability. We 
have previously shown that the combination of high pyrrole and a low N-oxide 70 
formation together with  little  hydrolysis were major factors  in the 
susceptibility of guinea pigs to intoxication by the PA jacobine (Chung and 
Buhler, 1993a). 
In Sprague-Dawley (SD) rats (Williams et al., 1989) and humans 
(Miranda et al., 1991b), the microsomal formation of pyrrole from SN is 
catalyzed primarily by enzymes belonging to the cytochrome P4503A 
subfamily. FMO accounts for no more than 20% of the PA N-oxidase activity 
of SD rat liver microsomes (Williams et al., 1989b). However, DHP formation 
from SN increased by only 47% in liver microsomes from dexamethasone (DEX) 
treated (P4503A inducible) guinea pigs while phenobarbital (PB) treatment 
(P4502B inducible) increased DHP production from SN by 270% (Miranda et 
al., 1992). We have previously demonstrated that spironolactone treatment 
(another inducer of P4503A) also increased pyrrole formation by only 50% 
from SN in hepatic guinea pig microsomes (Chung and Buhler, 1993b). 
Therefore, based on these findings we hypothesized that cytochrome 
P4502B isozyme was a more important enzyme in the guinea pig than P4503A 
in the bioactivation of PAs. To verify this conchisions, we have purified liver 
P450s from PB treated guinea pigs and carried out in vitro metabolism with 
SN in order to assess their importance in bioactivation and detoxification of 
this PA. We now present evidence that cytochrome P4502B plays the most 
important role in SN bioactivation in the guinea pig. 71 
Materials and Methods 
Chemicals 
SN was purified from extracts of Senecio jacobaea and the DHP and N-
oxide metabolite standard were prepared as previously described (Kedzierski 
and Buhler 1986b). Cholic acid from Sigma Chemical Co. (St. Louis, MO) was 
recrystallized from ethanol. Dilauroyl-L-phosphatidylcholine (DLPC), glucose-
6-phosphate, glucose-6-phosphate dehydrogenase, Lubrol PX, NADI)+, NADPH, 
phenobarbital (PB), Triton N-101 and w-aminooctylagarose (AOA) were 
obtained from the Sigma Chemical Co. (St Louis, MO). DEAE Sephacel was 
purchased from Pharmacia (Sweden). Hydroxylapatite (HAP) was obtained 
from Bio-Rad Laboratory (Richmond, CA). 
Microsomes Preparation 
Hartley guinea pigs (425 g, male and 8 weeks old from Simonson Inc. 
Gilroy, CA) were treated with 80 mg/kg of PB (solubilized with 0.07 N NaOH 
in saline) for 4 days. Animals were starved for 24 hr prior to killing. Liver 
was homogenized with 0.1 mM potassium phosphate buffer, pH 7.4, containing 
0.15 M KC1 and 1 mM EDTA.  Microsomes were prepared by standard 
differential centrifugation and stored in 0.1 M potassium phosphate buffer, pH 
7.4, containing 20 % glycerol and 0.1 mM EDTA at -80°C. 72 
Cytochrome P450 Purification 
Guinea pig cytochrome P450s were purified by the method of Guengerich 
and Martin (1980) and Oguri et al. (1991) with the following modifications (Fig. 
IV-1). Briefly, the solubilized microsomes (0.6% cholate) were applied onto an 
w-aminooctylagarose (AOA) column (2.6 x 21.5 cm). The P450s were eluted 
with 0.1 M KPi buffer (pH 7.25) containing 0.08% Triton N-101 and 0.33% 
sodium cholate. The eluent produced two peaks (AOA 1 and AOA 2) detected 
by absorbance at 417 nm (Fig. IV-2). Peak AOA 1 and AOA 2 fractions were 
collected, pooled, concentrated and then loaded onto a DEAE Sephacel (DEAE) 
column (2.6 x 37 cm), respectively, and eluted with a linear gradient of 0 to 0.2 
M NaC1 in 0.01 M KPi buffer (pH 7.7) containing 0.1% Lubrol PX and 0.2% 
sodium cholate.  The AOA 1 produced three peaks (DEAE 1, 2 and 3) as 
reflected by absorbance at 417 nm (Fig. IV-3), however, the P450 in the DEAE 
3 peak had degraded to P420. The pooled AOA 2 fraction, upon subsequent 
DEAE Sephacel column chromatography, gave a single major peak (DEAE 4) 
and several tiny peaks with absorbance at 417 nm. DEAE fractions 1, 2 and 
4 were further purified on a hydroxylapatite (HAP) column (1 x 18 cm). The 
proteins were eluted with a linear gradient of 0.01 to 0.125 M KPi buffer (pH 
7.7) containing 0.1% Lubrol PX and 0.2% sodium cholate. Chromatography of 
DEAE 1,2 and 4 fractions on hydroxylapatite yield three purified P450 fraction 
(HAP 1, 2 and 3). All steps were carried out at 4°C. 73 
Preparation of antibodies against purified guinea pig P450s 
Adult female New Zealand white rabbits (2.3 kg) were immunized 
intradermally at 20 sites along the flanks with 50 jig of the purified 
cytochrome P450s mixed with complete Freund's adjuvant (1:1 ratio).  One 
week later, rabbits were boosted intradermally with 50 jig of the immunogen 
in incomplete Freund's. After 3 weeks, animals were again boosted with a 
subcutaneous injection of 10 pg of the immunogen with incomplete Freund's. 
Two weeks later, blood was drawn and sera collected from each animal. Every 
3 weeks thereafter, rabbits were boosted with 10 jig of the purified P450s.  The 
specificity of the resulting antibodies was confirmed with Ouchterlony double 
diffusion analysis of sera as described by Thomas et al. (1976). 
Enzyme assays 
The in vitro metabolism of SN by rat liver microsome was carried out 
using the procedure described by Miranda et al. (1991a). A typical incubation 
consists of 0.3 mg of microsomal protein, 0.1 M KPi buffer, pH 7.6 or 8.6, 0.5 
mM SN, 1 mM EDTA and a NADPH-generating system (10 mM glucose-6-
phosphate, 1.0 units/mg glucose-6-phosphate dehydrogenase and 1 mM NADP+) 
in a total volume of 0.5 ml. After a 1 hr incubation (formation of DHP and N-
oxide was linear up to 1 hr under the assay conditions used) at 37°C, the 
reaction was terminated by rapid cooling on ice. The mixture was centrifuged 
at 46,000 g for 45 min at 4°C and an aliquot of the supernatant was analyzed 74 
by HPLC (Kedzierski and Buhler 1986).  The above protocol was slightly 
modified when anti-guinea pig P450 IgG serum was used to titrate the 
microsomal enzyme activity. The IgG serum (0 to 30 mg/nmole P450) and 0.3 
mg of microsomes were preincubated for 20 min at room temperature prior to 
the addition of other components. 
In reconstitutive experiments with purified guinea pig P450s, 0.4 nmole 
rat liver NADPH-cytochrome P450 reductase, 0.1 nmole P450 and 10 jig of L-a-
DLPC (sonicated prior to addition) were preincubated for 10 min at room 
temperature. Subsequently, 0.1 M KPi buffer (pH 7.6) and 0.5 mM SN were 
added to yield a total volume of 0.5 ml and preincubated at 37 °C for 3 min 
prior to initiation of the reaction with 1.5 mM NADPH.  After a 1 hr 
incubation, metabolites were analyzed using HPLC as described above. 
Benzphetamine N-demethylase assays were accomplished as described by 
Guengerich (1982). 
Other methods 
The amino terminal sequence of the purified guinea pig cytochrome 
P4502B was determined by an Applied Biosystems 475A gas-phase protein 
sequencer coupled with Edman degradation by the Central Analytical 
Laboratory of Oregon State University Center for Gene Research and 
Biotechnology. Mass spectrometry of the purified P450s was run as described 
by Lewis et al. (1993) using sinapinic acid (3,5- dimethoxy- 4- hydroxycinnamic 75 
acid) as the matrix and bovine serum albumin as the internal standard. The 
analyses were generously carried out by Ms. Elizabeth Barofsky in the Mass 
Spectrometry Core Facility of Oregon State University Environmental Health 
Sciences Center. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) was carried out as described by Laemmli (1970). Microsomal and 
purified cytochrome P450 protein contents were determined by the method of 
Lowry et al. (1951).  Total cytochrome P450 content was estimated using a 
spectral method (Omura and Sato 1964). 76 
Results 
Purification of P450s from guinea pig liver. 
Three P450 isozymes from liver microsome of PB treated guinea pigs 
were purified (Table IV-1). While the guinea pig P450s HAP 1 and 2 were 
catalytically active, HAP 3 which had been derived from DEAE 4 had lost its 
catalytic activity. The specific contents of the isolated HAP 1 and 2 were 10.2 
and 7.2 nmole/mg protein, respectively.  Each P450 was examined by 
immunochemical detection using anti-rat P4502B1, P4502C11 and P4503A2 
IgG (data not shown). Thus, HAP 1 was tentatively identified as a P4502B 
type; HAP 2 as a P4502C form; and HAP 3 as a P4503A ortholog. 
Characterization of purified P450s 
To help identify the P450 subfamilies of the isolated guinea pig 
isozymes, the molecular weights of the purified enzymes have been determined 
using a matrix-assisted laser desorption ionization on a time-of-flight (MALDI-
TOF) mass spectrometer with sinapinic acid as the matrix (Lewis et al., 1993). 
The molecular weight of guinea pig P4502B was determined to be 57,512 Da 
with BSA (66,431 Da) as the internal standard (Fig. IV-4).  Similarly, the 
molecular weight of guinea pig P4502C was 56,496 Da (Fig. IV-5). However, 77 
the mass spectrometry for P4503A isoform could not be attempted because this 
degraded isoform had shown two bands of P450 range on SDS-PAGE (data not 
shown). 
An NH2-terminal amino acid sequence of 39 residues for purified guinea 
pig P4502B was obtained (Fig. IV-6). The first 33 amino acids of our sequence 
was identical to that of P450Gp.1 sequence of 33 residues reported by Oguri et 
al. (1991).  This sequence had been shown to have a 79%, 71% and 69% 
homology with rabbit P4502B4 (Gasser et al., 1988), human P4502B1 (Yamano 
et al., 1989) and rat P4502B2 (Frey et al., 1985), respectively. 
Catalytic activity of purified P450s 
The catalytic  activities  of purified guinea pig liver P450s and 
microsomes are summarized in Table IV-2.  In reconstitution experiments, 
purified guinea pig P4502B converted SN to DHP and SN N-oxide at rates of 
0.65 and 1.50 ranole/min/nmole P450, respectively.  In contrast, hepatic 
microsomes from PB treated guinea pigs increased DHP formation by 224% 
and SN N-oxide by 70%. In reconstitution experiments, the P4502C isoform 
produced SN N-oxide from SN at the rate of 13.3 nmole/mininmole P450 
whereas DHP formation was minimal. The P4503A isoform had lost its 
activity during the final purification processes and, consequently, its enzymatic 
activity could not be determined. 78 
Immunoinhibition of microsomal SN metabolism by anti-guinea pig P450s IgG 
Titration of SN metabolism by rabbit anti-guinea pig cytochrome P4502B 
IgG inhibited 69% of DHP formation in hepatic microsomes from untreated 
guinea pigs. while only 43% and 14% of DHP formation were inhibited by 
P4502C and P4503A IgG, respectively (Fig. IV-7). Using microsomes from PB 
treated guinea pigs, immunoinhibition of DHP formation from SN by anti-
guinea pig P4502B IgG was 70% compared to only 11% and 13% by antibody 
against purified guinea pig P4502C and P4503A IgG, respectively (Fig. IV-8). 
Differences in the absolute inhibition of microsomal DHP formation between 
untreated and PB treated guinea pigs by P4503A IgG confirmed that PB also 
induced P4503A isozyme in this species.  The decreased percentage of 
contribution to DHP formation by P4502C in PB treated guinea pigs suggests 
that the P4502C isoform was refractory to PB induction. The results of the 
immunoinhibition studies on microsomal DHP formation using anti-cytochrome 
P450 IgGs indicated that in guinea pigs P4502B was the most important 
enzyme (up to 70%) for activation of SN in both untreated and PB-treated 
animals. P4503A isoform, however, had only a small (about 13%) contribution 
to DHP formation in both untreated and PB-treated guinea pigs. P4502C was 
estimated to be responsible for 43% of the SN converted to DHP in untreated 
guinea pigs while only 11% in PB-treated animals. 79 
Titration of microsomal SN metabolism by rabbit anti-guinea pig 
cytochrome P4502B IgG inhibited 34-40% of SN N-oxidation in untreated and 
PB treated guinea pigs while less than 20% of SN N-oxide formation was 
inhibited by P4502C and P4503A IgG, respectively (Fig. IV-9 and rv-10). 
Therefore, it seems that P4502B also played some role (up to 40%) in 
detoxification of SN and P4502C and P4503A had only a minimal influence on 
SN detoxification in both untreated and PB treated guinea pigs. 80 
Discussion 
Three P450 isoforms were purified from liver microsomes of PB treated 
guinea pigs in order to assess the role of these enzymes in PA metabolism. 
After tentative identification of these isozymes with western blots, we 
employed MALDI-TOF mass spectrometry which has been recently developed 
for determination of mass of large molecules such as biopolymers.  This 
MALDI-TOF mass spectrometry has been used to provide an accurate 
molecular weight determination of rat P4502B1/2 within 0.075% error (Lewis 
et al., 1993).  Therefore, we are able to report the very precise molecular 
weights of guinea pig cytochrome P4502B and P4502C to be 57,512 and 56,496, 
respectively, under the experimental conditions used. 
By contrast, Oguri et al. (1991) reported the molecular weight of P450Gp.1, 
which was identical to P4502B based on the amino terminal sequence, as 
52,000 based on SDS-PAGE estimation. SDS-PAGE has been the traditional 
method for assessment of the molecular weight of P450s.  This method, 
however, was not always consistent with the cDNA-derived amino acid 
sequence values (Levin et al., 1984) probably due to the influence, such as 
glycosylation,  other  post-translation  modifications,  or  P450s'  high 
hydrophobicities which interact with sodium dodecyl sulfate, on their migration 
in SDS-PAGE. Also the actual molecular weight range of P4502B family in 81 
other species, estimated by cDNA-derived amino acid sequence, is reported to 
be 55,000 to 56,000 (Frey et al., 1985; Gasser et al., 1988; Yamano et al., 1989). 
We next evaluated the catalytic activities of the purified guinea pig P450 
isoforms in reconstituted systems for PA metabolism using SN as the 
substrate. We also determined the relative roles of these P450s through the 
use of immunoinhibition experiments in the microsomal metabolism of SN. 
Unfortunately, the results of the reconstitutive experiments did not always 
agree with those inferred from the  immunoinhibition studies.  In 
reconstitution experiments, purified P4502B converted SN to DHP and SN N-
oxide at rates of 0.65 and 1.50 nmole/min/nmole P450, respectively. 
Pretreatment with PB (an inducer of cytochrome P4502B1) also significantly 
increased conversion of SN to both DHP and SN N-oxide in microsomes. 
However, titration of microsomal SN metabolism by anti-guinea pig P4502B 
IgG inhibited of DHP formation about 70% in both untreated and PB treated 
guinea pigs. This suggests that the rabbit anti-guinea pig P4502B IgG also 
may have been inhibiting other P450 isoforms involved in DHP production. 
Reconstituted cytochrome P4502C produced SN N-oxide from SN at the 
rate of 13.3 nmole/min/nmole P450 whereas DHP formation was at a minimal 
rates. However, the P4502C IgG inhibited 43% of microsomal DHP formation 
from SN but only 19% of SN N-oxidation in untreated guinea pigs.  82 
Turnover numbers in a reconstituted enzyme system do not always 
reflect contribution of the enzyme in intact microsomes. Sundheimer et al. 
(1983) also showed that rat P448mc (P4501A1) catalyzed acetanilide 4-
hydroxylation in a constituted system, but did not contribute in  3-
methylcholanthrene induced rat liver microsomes. 
The microsomal formation of pyrrole from SN is catalyzed primarily by 
enzymes belonging to the cytochrome P4503A subfamily in rats (Williams et 
al., 1989a) and humans (Miranda et al., 1991b). However, we observed that 
cytochrome P4502B played the most important role (over 70% of the SN 
bioactivation) in the guinea pig, even though P4502B had a minimal specific 
activity toward the PA SN. This phenomenon reveals that metabolism by one 
P450 by itself in reconstitutive systems is quite different from how that P450 
behaves in a mixture of P450s. Especially it is noteworthy that the amounts 
of enzymes involved in SN bioactivation overcomed the low specific activity of 
P4502B for pyrrole formation from the PA SN in the guinea pig. 
Recently, Ohmori et al. (1993) demonstrated by immunoquantification 
that P4502B isoform comprised 47% of total P450 in liver microsomes of 
untreated guinea pig while P4502B1 was less than 0.1% of total P450 in 
untreated rat. However, P450282 is constitutively expressed in the liver of 
rats while P4502B1 is absent in liver until PB treatment and is constitutively 
expressed in lung and testis (Traber et al., 1988). By contrast, P4502C6, 83 
P4502C11 and P4503A2 are major constitutive isoforms found in the rat 
(Imaoka et al. 1991). In guinea pigs, P4501A1, P4503A and P45017 are known 
to be other constitutive forms (Nelson et al., 1993). Therefore, difference in the 
major constitutive P450s present in the livers of rats and guinea pigs may help 
explain the apparent disparity in the major enzymes for bioactivation of PA 
between these two species. 
Miranda et al. (1991a) reported that hepatic FMO was a major enzyme 
for N-oxidation of SN in the guinea pig.  In the present study, cytochrome 
P4502B seemed to play some role (up to 30% of the N-oxidation). This was the 
greatest contribution among the P450 isozymes tested, suggesting that P4502B 
was involved in detoxication of the PAs by the guinea pig.  Hence, next to 
FMO, P4502B is the second most important enzyme for the detoxication of SN 
in the guinea pig. 
In conclusion, cytochrome P4502B isoform was the most important 
enzyme for the bioactivation of the PA SN in the guinea pig while P4503A2 
was the most important in the rat. By contrast, FMO was a major enzyme for 
SN N-oxidation while P4502B isoform played some role in SN N-oxidation in 
the guinea pig. 84 
Table IV-1.  Purification of cytochrome P450s from liver microsome of 
phenobarbital treated guinea pigs. 
Protein  Specific activity Total P450 Recovery 
(mg)  (nmole/mg)  (nmole)  (%) 
Microsomes  905  1.01  1068  100 
Solubilized Mic.  886  0.86  758  71 
AOA 1  93  3.93  365  34 
DEAE 1  59  4.79  283  26 
HAP 1  14  10.21  143  13 
DEAE 2  8  3.63  29  2.7 
HAP 2  0.7  7.24  5  0.5 
DEAE 3  3  0  0  0 
AOA 2'  95  1.38  132  12 
DEAE 4  4.7  3.81  18  1.7 
HAP 3  0.96  1.40  1.34  0.1 85 
Table  IV-2. The catalytic activities of guinea pig hepatic microsomes and 
purified guinea pig liver cytochrome P450s. 
Protein	  Substrate  Specific activity* 
Control microsome  Benzphetamine  8.54 ± 1.2 
SN  to DHP  0.69 ± 0.1 
to N-oxide  2.43 ± 0.2 
PB microsome  Benzphetamine  24.9 ± 2.7 
SN  to DHP  2.2 ± 0.7 
to N-oxide  4.1 ± 0.9 
HAP 1 (P4502B)  Benzphetamine  53.2 
SN  to DHP  0.65 
to N-oxide  1.52 
HAP 2 (P4502C)  SN	  to DHP  0.08 
to N-oxide  13.3 
HAP 3 (P4503A)  SN	  to DHP 
to N-oxide 
*Activities were expressed as the mean ± SD. for microsomes and HCHO 
nmole/min/mg microsomal protein for benzphetamine d-methylation and DHP 
or SN N-oxide nmole/min/mg protein for SN.  Activities were the mean of 
duplicated determination for purified P450s and HCHO, DHP or SN N-oxide 
nmole/min/nmole P450. 
'The catalytic activity of P4503A isoform have been lost during purification 
steps. 86 
PB-Microsomes 
w-aminooctyagarose column 
AOA 1  AOA 2 
DEAE column  DEAE column 
I 
DEAE 1  DEAE 2  DEAE 3  DEAE 4  
(degradation)  
HAP column  HAP column  
P4502B  P4502C  P4503A  
Fig. IV-1. An. outline of the purification of guinea pig liver cytochrome P450s. 87 
AOA 1 
CI 
0.8%  Triton 
N-101 
0% Triton  
N-101  
AOA 2 
0  1 0 0  2 0 0 
FRACTION 
Fig.  IV-2.  Elution  profiles  of w-aminooctylagarose (AOA) column 
chromatography for the purification of guinea pig liver P450s. 86 
0 
0 
0
0 1 
047 
16-o 89 
57511.9  
P4502B 
Q; 
C") 
CDj:7) 
P4502B  
1VIH2"  
44,0 t)1,1  t 
30000  m/z  70000  
Fig.  IV-4.  Matrix-assisted laser desorption ionization on a time-of-flight 
(MALDI-TOF) mass spectrum of guinea pig liver P4502B. 0.45 lig of P4502B 
was loaded with BSA (66,431 Da) as the internal standard. Sinapinic acid was 
used as the matrix. 90 
66431.1  
+ BSA 
NM+ 
P4502C 
csz n 
P4502C 
MEI+ 
6\AW 
1/Afwa.,A,  f\-4kAil 
30000  11/Z  70000 
Fig.  P1 -5.  Matrix-assisted laser desorption ionization on a time-of-flight 
(MALDI-TOF) mass spectrum of guinea pig liver P4502C type.  0.26 pg of 
P4502C was loaded with BSA (66,431 Da) as the internal standard. Sinapinic 
acid was used as the matrix. 91 
1 5  10 
MET-GLU-LEU-SER-LEU-LEU-LEU-PHE-LEU-ALA-
11 15  20 
LEU-LEU-LEU-GLY-LEU-LEU-LEU-LEU-LEU-PHE-
21 25  30 
LYS-GLY-HIS-PRO-LYS-ALA-HIS-GLY-ASN-LEU-
31 35  40 
PRO-PRO-GLY-PRO-HIS-PRO-LEU-PRO-PHE-(LEU)-(GLY)-
Fig. IV-6. The amino terminal sequence of guinea pig cytochrome P4502B. 92 
1.2 
"al  1.0 
48 
O  
al 0.8  
0.6
O . 
cy.:( 1 
44 0.4  
A 0  
g  0.2 
0.0
0  10  20  30  40 
ANTIP450 IgG 
(mg/nmole P450) 
Fig. IV-7. Immunoinhibition of DHP formation in untreated guinea pig liver 
microsomes by anti-P450 IgGs [Preimmun IgG ( 0); Anti-P4503A IgG (); 
Anti-P4502C IgG (0); Anti-P4502B IgG (0)1 93 
0  10 20 30 40  
ANTI-P450 IgG  
(mg/nmole P450)  
Fig.  IV-8.  Immunoinhibition of DHP formation in phenobarbital-treated 
guinea pig liver microsomes by anti-P450 Ig Gs [Preimmun IgG ( 0 ); Anti-
P4503A IgG (1111); Anti-P4502C IgG (0); Anti-P4502B IgG (0)1 94 
---0 (100% ) 
u (90%) 
(81 %) 
(66%) 
I 0.0 
0  10 20 30 40 
ANTI-P450 IgG 
(mg/nmole P450) 
Fig. IV-9. Immunoinhibition of SN N-oxide formation in untreated guinea pig 
liver microsomes by anti-P450 IgGs [Preimmun IgG (0); Anti-P4503A IgG 
($); A'nti-P4502C IgG (0); Anti-P45028 IgG ()]. 95 
I , 
10 20  30  40 
ANTI-P450 IgG 
(mg/nmole P450) 
Fig.  IV-10.  Immunoinhibition of SN N-oxide formation in phenobarbital-
guinea pig liver microsomes by anti-P450 Ig Gs [Preimmun IgG (0 ), Anti-
P4503A IgG (1111); Anti-P4502C IgG (D); Anti-P4502B IgG (0)]. 96 
V. HIGH CAPACITY FOR PYRROLE FORMATION TOGETHER WITH 
LOW RATES OF N-OXIDATION AND LITTLE HYDROLYSIS ARE THE 
MAJOR FACTORS FOR THE SUSCEPTIBILITY OF GUINEA PIG TO 
THE PYRROLIZIDINE ALKALOID JACOBINE* 
Woon-Gye Chung and Donald R. Buhler. 
Toxicology Program, Oregon State University, Corvallis, OR 97331. 
This study was supported by NIH Grants CA22524 and ES00210.  This 
manuscript was assigned Oregon State University Agricultural Experimental 
Station No. 97 
Abstract 
Guinea pigs are resistant to the toxicities of pyrrolizidine alkaloids 
(PAs). However, the PA jacobine (JB) is unusually toxic to this species. To 
investigate the potential for esterlytic cleavage of PAs, we have initially 
purified two forms of hepatic carboxylesterase (GPL1 and GPH1) from guinea 
pigs.  The major form GPL1 was purified to a specific activity of 486 
pmole/min/mg protein in hydrolysis of p-nitrophenyl acetate (NPA) while the 
minor form GPH1 yielded p-nitrophenol with a specific activity of 86 
}mole /min/mg protein from NPA. The metabolism of the highly toxic PA ['H]-
JB and PA [311]-senecionine (SN) which has lower toxicity then were studied 
using the purified guinea pig carboxylesterases and guinea pig liver 
microsomes. Purified carboxylesterase (GPH1) hydrolyzed [3H] -JB and [3H] -SN 
at rates of 4.5 and 11.5 nmole/min/mg protein, respectively. Carboxylesterase 
GPL1, however, had no activity toward PAs. Liver microsomes converted [3H]-
JB to the pyrrolic metabolite (±)6,7- dihydro -7- hydroxy- 1- hydroxymethyl -5H-
pyrrolizine (DHP) and JB N-oxide at rates of 0.329 and 0.104 nmole/min/mg 
protein (DHP/N-oxide ratio: 3.16). Conversely, liver microsomes produced DHP 
and SN N-oxide from [3H] -SN at rates of 0.460 and 0.865 nmole/min/mg protein 
(DHP/N-oxide ratio: 0.53). Therefore, we concluded that the combination of 
high pyrroles and low N-oxide formation and little hydrolysis are the major 
factors responsible for intoxication by guinea pigs by the PA JB. 98 
Abbreviation: Con-A, concanavalin A-Sepharose 4B; DE 52, diethylaminoethyl 
cellulose 52; DHP, (±)6,7-dihydro-7-hydroxy-l-hydroxymethy1-5H-pyrrolizine, 
FMO, flavin-containing monooxygenase; HAP, hydroxylapatite; HPLC, high 
performance liquid chromatography; JB, jacobine; MN, monocrotaline; NPA, 
p-Nitrophenyl  Acetate;  PAs,  Pyrrolizidine  alkaloids;  PMSF, 
phenylmethylsulfonyl fluoride;  RT, retrorsine;  SN, senecionine;  SP, 
seneciphylline. 99 
Pyrrolizidine alkaloids (PAs) occur in several species of plants. The 
widespread geographical distribution of PA-containing plants results in 
hepatotoxicity and livestock losses throughout the world (Fowler, 1968). PAs 
are metabolized by liver monooxygenases yielding PA pyrroles and N-oxides. 
PA pyrroles are considered the ultimate toxic metabolites whereas PA N-oxides 
are believed to be non-toxic. The PA pyrroles either react with cellular 
macromolecules or are hydrolyzed to form a secondary pyrrole known as (±) 
6,7-dihydro-7-hydroxy-1-hydroxymethy1-5H-pyrrolizine (DHP). 
Hydrolysis of a toxic pyrrolizidine ester leads to the necine and necic 
acid moieties, neither of which are hepatotoxic; thus hydrolysis amounts to 
detoxication (Mattocks, 1982). Treatment of rats with an esterase inhibitor, 
triorthocresylphosphate, increased the hepatotoxicities of PAs due to the larger 
portion of the dose available for conversion to toxic metabolites (Mattocks, 
1970). Hosokawa et al. (1990) purified two isozymes of carboxylesterase, with 
nomenclature of GPL1 and GPH1, from guinea pig liver. Purified guinea pig 
GPH1 hydrolyzed SP, MN and SN, however, only minimal activity was seen 
with SN (Dueker et al., 1992b). The hydrolytic activity for PAs by purified 
guinea pig carboxylesterase varies appreciably depending on the structure of 
PAs (Dueker et al., 1992b). 
Guinea pigs are known to be very resistant to the toxicities of the PAs 
monocrotaline (MN) (Chesney and Allen, 1973) and retrorsine (RT) (White et 
al., 1973), but very susceptible to seneciphylline (SP) (Chen et al., 1940) and 100 
jacobine (JB) (Swick et al., 1982). The objective of this study was to determine 
which factors were responsible for the high toxicity of JB in guinea pigs. We 
have purified carboxylesterase from guinea pig liver and then assayed the 
enzymes for hydrolytic activity against JB and SN. We present evidence that 
the combination of high rates of activation (pyrrole production), low N-
oxidation (detoxication) and little hydrolysis to the nontoxic retronecine were 
responsible for the high toxicity of JB to the guinea pig. 101 
Materials and Methods  
Chemicals- Tritiated jacobine and senecionine (99.7% of tritium resided 
in the necine base) were made biosynthetically in Seneciojacobaea as described 
previously (Reed et al, 1985; Reed and Buhler, 1988). p-Nitrophenyl acetate 
(NPA), methyl a-D-mannopyranoside and concanavalin A-sepharose 4B (Con 
A-sepharose) were purchased from Sigma Chemical Co. (St. Louis, MO). DE-52 
anion exchange resin was purchased from Whatman (Maidstone, KY). 
Hydroxylapatite (HAP) was obtained from Bio-Rad Lab. (Richmond, CA). 
Optifluor scintillation cocktail was from Packard Canberra Company (Downers 
Grove, IL). 
Preparation of microsomes-Hartley guinea pigs (400-450 g and 8 weeks 
old males) were purchased from Simonson Inc. (Gilroy, CA). Five animals 
were anesthetized with an overdose of CO2 and killed by decapitation. The 
livers were quickly removed and homogenized with 0.1 M Tris-acetate buffer, 
pH 7.5, containing 0.1 M KC1 and 1 mM EDTA. Microsomes were prepared by 
standard differential centrifugation at 9000 g for 30 min and at 105,000 g for 
60 min at 4 °C. The microsomes were stored in 10 mM Tris-acetate buffer, pH 
7.4, containing 1 mM EDTA, 1 mM PMSF and 20 % glycerol at -80 °C until 
used. 102 
Purification of Carboxylesterases-Microsomal carboxylesterases were 
purified by the methods of Harano et al. (1988) and Dueker et al. (1992b) with 
the following modifications (Fig. V-1).  All steps were carried out at 4 °C. 
Microsomes (672 mg) were solubilized in buffer A (50 mM Tris-HC1, pH 7.4, 1 
mM CaC12, 1 mM MgC12 and 1 mM MnC12) containing 1 % Triton X-100 at a 
final protein concentration of 3 mg/ml. The solution was stirred for 90 min 
and centrifuged at 105,000 g for 90 min.  The supernatant was applied to a 
Con A-sepharose column (1 x 12 cm) preequilibrated with the filtered buffer A 
containing 1 % Triton X-100 in a flow rate of 30 ml/hr. The column then was 
washed with 100 nil of buffer A containing 1 % Triton X-100 and 0.5 M NaC1 
and then washed with 100 ml of buffer A. The column was eluted with 200 ml 
of buffer A containing 0.5 M methyl a-D-mannopyranoside. The eluent was 
concentrated to 10 ml on an Amicon 8200 membrane concentrator with a PM 
30 Diaflo filter and concentrated again after adding 100 ml of 10 mM Tris-HC1 
buffer (pH 8.0) and dialyzed with 12000-14000 MW cut Spectrapor 
molecularporous membrane against 1 liter of 10 mM Tris-HC1 buffer (pH 8.0) 
at 4 °C for 22 hr. The dialyzed fraction was applied to a Whatman DE-52 
column (1 x 12 cm) preequilibrated with the dialyzed buffer. The column was 
eluted with a linear gradient of 0 to 200 mM NaC1 in 10 mM Tris-HC1 buffer 
with a flow rate of 20 ml/hr.  Absorbance was monitored at 254 nm and 
esterase activity (2 Ill aliquats of each fraction) was determined at 405 nm 
using p-nitrophenyl acetate as described by Krisch (1966).  DE-52 fractions 103 
produced three peaks of esterase activity. Tubes making up the these active 
fractions were combined, concentrated, dialyzed against 500 ml of 10 mM 
potassium phosphate buffer (pH 7.0) for 16 hr and each was then applied to a 
hydroxylapatite column (1 x 20 cm) equilibrated with the dialyzed buffer. 
Carboxylesterases were purified by elution with a linear gradient of 10 to 400 
mM of potassium phosphate buffer (pH 7.0) after washing with 50 ml of 10 
mM buffer. Esterase activity (2 - 10 pl) was monitored. Active fractions were 
combined and concentrated to 10 mM Tris-HC1 buffer (pH 8.0) and stored at -
80 °C until assayed. Protein was determined by the procedure of Lowry et al. 
(1951) with bovine serum albumin as a standard. Purity was determined by 
SDS-PAGE as described by Laemmli (1970) with 8 % acrylamide gel. 
Determination of hydrolysis rates-The hydrolysis of p-nitrophenyl acetate 
(1.6 mM) was determined colorimetically in 50 mM Tris-HC1 buffer (pH 8.0) 
at 25 °C by measuring the release of p-nitrophenol at 405 nm according to the 
method of Kirsch (1966). 
The hydrolysis of PAs was carried out using 0.1 M potassium phosphate 
buffer, pH 7.4, 0.5 mM [3H] -SN (0.58 pCi/pinole) or [3H] -JB (0.44 pCi/pinole), 
0.4 pg (14 nM) of carboxylesterase in a total volume of 0.5 ml for 1 hr at 37 °C. 
The reaction was terminated by rapid cooling on ice. An 100 to 300 pl aliquot 
was injected onto the PRP-1 column (Hamilton, Reno, NV) and eluted with 5% 104 
acetonitrile and 0.01 N NH4OH with a flow rate of 1.5 ml/min. The eluent was 
added to optifluor cocktail and counted using a Tri-Carb liquid scintillation 
analyzer (Downers Grove, IL). 
The in vitro metabolism of JB and SN by microsome from guinea pig 
liver was carried out using the procedure described by Miranda et al. (1991a). 
A typical incubation consisted of 0.3 mg microsomal protein, 0.1 M potassium 
phosphate buffer, pH 7.6, 0.5 mM [3H] -SN or [3H] -JB, 1 mM EDTA and 0.1 mM 
NADPH in a total volume of 0.5 ml. After a 1 hr incubation at 37°C, the 
reaction was terminated by rapid cooling on ice. The mixture was centrifuged 
at 46,000 g for 45 min at 4°C and an aliquot of the supernatant was analyzed 
by HPLC (Kedzierski and Buhler, 1986a).  The eluent was analyzed as 
described above. 105 
Results 
Purification of carboxylesterases from guinea pig hepatic microsomes-
Carboxylesterases were purified from guinea pig liver in order to assess their 
roles in PA detoxication.  Two isozymes, GPL1 and GPH1, were purified as 
described by Hosokawa et al. (1990). At each step, the hydrolytic activity 
toward NPA was monitored. Con A chromatography produced an eight-fold 
increase in specific activity (Table V-1). DE 52 fractions produced three peaks 
of esterase activity. Each pooled fraction was applied onto hydroxylapatite 
column. DE 52-1 and DE 52-2 fractions produced only one peak (HAP 1 and 
HAP 2, respectively), but DE 52-3 fraction formed four peaks of esterase 
activity (HAP 31, 32, 33 and 34) (Fig. V-2). HAP 1, 2, 31 and 32 had mobilities 
with a molecular weight of 60,000 in SDS-PAGE, which is similar to that of 
GPL1 (Hosokawa et al., 1990) (Fig. V-3). However, HAP 33 and 34 exhibited 
mobilities with a molecular weight of 57,000, similar to GPH1 (Hosokawa et 
al., 1990), with slight contamination of GPL1. Six different fractions showed 
different specific activities toward NPA (Table V-1). 
Hydrolysis of PAs by carboxylesterases-The guinea pig carboxylesterases 
hydrolyzed PAs to a necic acid and a necine base (retronecine). We incubated 
[3H] -SN and [3H] -JB with the six fractions of carboxylesterases in order to 
verify their roles in PAs detoxification. The GPL1-type fractions, HAP 1, 2, 31 
and 32, had no hydrolytic activities toward SN or JB (Table V-2).  These 106 
results agreed with Dueker et al. (1992b). HAP 33 and 34, a GPH1 type 
fractions, hydrolyzed SN at low rates. Only HAP 34 hydrolyzed JB at a lesser 
rate than that of SN. 
Tritiated PAs metabolism by guinea pig liver microsomes-Liver 
microsomes converted JB to the pyrrolic metabolite (±)6,7-dihydro-7-hydroxy-1-
hydroxymethy1-5H-pyrrolizidine (DHP) and JB N-oxide at rates of 0.329 and 
0.104 nmole/min/mg protein giving a DHP/N-oxide ratio of 3.16 (Table V-3). 
In contrast, liver microsomes produced DHP and SN N-oxide from SN at rates 
of 0.460 and 0.865 nmole/min/mg protein yielding a DHP/N-oxide ratio of 0.53. 
Therefore, the metabolism of SN by guinea pig liver microsomes was 3-fold 
higher than that of JB. Furthermore, the JB metabolism by guinea pig liver 
microsomes showed a tendency forward the increased toxicity in this animals. 107 
Discussion 
One of the most curious things to toxicologists is why some animals are 
resistant to the toxicity of a chemical but others are not, and why some 
chemicals produce toxicity in an animal but others do not. Guinea pigs have 
been studied as the resistant species against the toxicity of PAs (Chesney and 
Allen,  1973), however, guinea pigs have been known to be unusually 
susceptible to JB intoxication (Swick et al., 1982). Once ingested by an animal, 
PAs may be excreted, be activated by conversion to toxic metabolites or be 
detoxified to harmless metabolites which can then be eliminated from the body. 
The biological effects of ingested PAs will depend on the balance of these three 
pathways. The major known routes of metabolism of PAs are hydrolysis, N-
oxidation and dehydrogenation to pyrroles derivatives. The last is the only one 
known to be associated with cytotoxicity. We have attempted to answer why 
JB was so toxic to guinea pigs. 
Dueker et al. (1992a) reported that guinea pig hepatic microsomes 
hydrolyzed MN, while the rat exhibited no such hydrolytic capabilities (Lame 
et al., 1991). We purified carboxylesterase GPL1 and GPH1 from guinea pig 
liver and assayed for hydrolytic activity against SN and JB. As observed by 
Dueker et al. (1992a), GPL1 had no activity toward PAs (Table V-2). SN was 
a better substrate for the GPH1 carboxylesterase than was JB (Table V-2). 108 
This means that JB ingested by an animal is more resistant to degradation by 
esterlytic cleavage than is SN. Consequently, greater quantities of JB remain 
available for conversion to toxic pyrroles. 
Mattocks (1982) illustrated that steric hindrance around the ester 
groups was.a major factor inhibiting hydrolysis. The only structural difference 
between JB and SN is an epoxide between C-15 and C-20 position in JB (Fig. 
V-4). There is thus, a possibility that the epoxide of JB may interfere with 
hydrolysis at 0-17 near to the C-15 position, an effect was not possible with 
SN. 
However, differences in the hydrolytic capability toward PAs by an 
animal can not fully explain the resistance of the animal to PA intoxication. 
It is necessary, therefore, to also consider the capability of the animal to 
convert PAs to reactive pyrroles and relatively harmless N-oxides since guinea 
pigs were very susceptible to the toxicity of the PAs such as seneciphylline (SP) 
(Chen et al., 1940) even though purified guinea pig carboxylesterase GPH1 had 
the highest activity toward SP among PAs studied (Dueker et al., 1992a). We 
have now examined the capacity of these other metabolic pathways of PAs in 
guinea pig liver microsomes to help explain these differences. 
Little consideration for pyrrole and N-oxide formation from JB has been 
attempted. We measured JB N-oxide during HPLC by its absorbance at 210 
nm. However, due to the low absorbency of JB N-oxide its limit of detection 
is much larger (2.5 nmole) compared to that of SN N-oxide (0.3 nmole). We  109 
have used rill labeled JB and SN to determine pyrrole and N-oxide formation 
by guinea pig liver microsomes. JB and SN produced similar amounts of DHP 
in microsomal incubations but JB yielded much less N-oxide compared to SN. 
The ratio of DHP/N-oxide formed from JB was 6 times higher than that from 
SN, which contributes to the greater availability of JB pyrrole for bioactivation. 
Therefore, we concluded that the limited hydrolysis as well as the high pyrrole 
and low N-oxide formation rates were primarily responsible for unusual 
toxicity of JB to guinea pigs. 
Miranda et al. (1991a) demonstrated that FMO was a major enzyme for 
N-oxidation of SN and cytochrome P450 mainly was responsible for DHP 
formation. SN had a high partition coefficient like 6.3 (Mattocks and Bird, 
1983a). There was no report about partition coefficient of JB. However, we 
can presume that the partition coefficient of JB is lower than that of SN 
because the solubility of JB in water is higher. The most lipophilic PAs are 
metabolized at the fastest rates (Mattocks and Bird, 1983a). Therefore the low 
lipophilicity of JB may delay its access to FMO, which has little opportunity 
for N-oxidation of JB and yield low JB N-oxidation. 
In conclusion, we have purified carboxylesterase from guinea pig liver 
and assayed for hydrolytic activity toward the PAs JB and SN. This study 
presented evidence that the combination of high pyrrole activation and low 
rates of detoxification via N-oxidation and hydrolysis are the major factors in 
the unusual susceptibility of guinea pigs to intoxication by the PA JB. 110 
Table V-1.  Purification of carboxylesterases from guinea pig hepatic 
microsomes. 
Protein  Specific activity*  Total  Recovery 
(mg)  activity*  (%) 
Microsomes  672  10.9 ± 1.0  7318  100.0 
Solubilizedf  601  9.9 ± 1.1  5964  81.5 
Con A-Sep.  29.8  85.9 ± 6.4  2559  35.0 
DE 52-1  2.86  239.1 ± 13  684  9.3 
HAP 1 (GPL1)  0.37  485.9 ± 10  178  2.4 
DE 52-2  5.61  88.3 ± 14  496  6.8 
HAP 2 (GPL1)  0.23  270.0 ± 32  61  0.8 
DE 52-3  2.05  65.0 ± 6.2  133  1.8 
HAP 31 (GPL1)  0.04  159.1 ± 11  6.8  0.09 
HAP 32 (GPL1)  0.14  24.3 ± 3.0  3.5  0.05 
HAP 33 (GPH1)  0.03  42.7 ± 2.5  1.4  0.02 
HAP 34 (GPH1)  0.07  85.8 ± 5.9  6.4  0.08 
*Specific activities toward NPA are the mean ± SD for 4 incubations and  
expressed as pmole p-nitrophenonnin/mg protein.  
*Total activities are expressed as mnole/min.  
iSolubilized means the supernatant of solubilized microsomes.  111 
Table V-2. Hydrolysis of pyrrolizidine alkaloids by purified carboxylesterases. 
HAP 1  HAP 2  HAP 31  HAP 32  HAP 33  HAP 34 
(GPL1)  (GPL1)  (GPL1)  (GPL1)  (GPH1)  (GPH1) 
[3H] -JB  ND*  ND  ND  ND  ND  4.5 
[3H] -SN  ND  ND  ND  ND  4.2  11.5 
*Activities are expressed as nmole retronecine/min/mg protein.  Data are  
represented as the mean for duplicate incubations.  
*ND means "not detectable".  112 
Table V-3. Conversion of the PAs senecionine and jacobine to DHP and N-
oxide by guinea pig liver microsomes. 
DHP  N-oxide  DHP/N-oxide 
[311]-JB  0.329*  0.104  3.16 
[3H] -SN  0.460  0.865  0.53 
*Activities are expressed as nmole/min/mg protein. Data are represented as 
the mean for duplicate incubations. 113 
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Fig. V-1. An outline of the purification of guinea pig liver carboxylesterases. 114 
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Fig. V-2. Carboxylesterase isolation. Hydrolysis of p-nitrophenyl acetate by 
hydroxylapatite column fractions. The first peak was defined as HAP 31 and 
then as HAP 32, HAP 33 and HAP 34. The elution of HAP 1 and HAP 2 in 
hydroxylapatite column appeared identical to that of HAP 31. 115 
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albumin; 80,000, Ovalbumin 49,500), Lane 2; HAP 1, Lane 3; HAP 2, Lane 
4; HAP 31,  Lane 5; HAP 32,  Lane 6; HAP 33,  Lane 7; HAP 34.  All 
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VI. Conclusions 
Once ingested by an animal, PAs may be excreted, be activated by 
conversion to toxic metabolites or be detoxified to harmless metabolites which 
can then be eliminated from the body. The biological effects of ingested PAs 
will depend on the balance of these three pathways. The major known routes 
of metabolism of PAs are hydrolysis, N-oxidation and dehydrogenation to 
pyrrole derivatives. The latter is the only one known to be associated with 
cytotoxicity. 
In this study, we provided evidence about species/strain differences 
between the rat, a susceptible species, and the guinea pig, a resistant species, 
in PAs bioactivation and detoxication in terms of the role of P450s, flavin-
containing monooxygenases (FMOs) and carboxylesterases.  FMO was 
responsible for N-oxidation (detoxication) of the PA senecionine (SN) in both 
sexes of Fischer 344 (F344) rats, compared to P4502C11 in Sprague-Dawley 
(SD) rats.  Also SN N-oxidation in F344 rats was higher than in SD rats. 
These results suggest that F344 rats may be refractory to the PAs intoxication 
because their enzymes preferentially N-oxidize PAs, therefore, leaving less 
opportunity for the products of cytotoxic dehydrogenated pyrrole derivatives. 
Cytochrome P4502B played the most important role in the bioactivation of the 
PA SN in guinea pigs while cytochrome P4503A2 is a major enzyme for pyrrole 118 
formation from SN in SD rats. The combination of high capacity for pyrrole 
activation and low detoxification via N-oxidation and hydrolysis were the major 
factors of the susceptibility of guinea pigs to the unusual toxic PA jacobine. 
A single factor can not explain the species/strain differences in 
susceptibility of an animal to the toxicities of PAs. Distinct enzyme systems 
and/or amounts available and unique substrate specificities altogether may 
explain the differences between animal species in toxicities of the PAs. 119 
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